Disorders of refraction and accommodation

H7_REFRAACCOMMODIS

obsolete_refractive error: ['Deviations from the average or standard indices of refraction of the eye through its dioptric or refractive apparatus.']

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H52 Cause of death: ICD-10 — H52 2 out of 7 registries used, show all original rules.	15772
4. Check minimum number of events None	15772
5. Include endpoints H7_HYPERMETRO H7_MYOPIA H7_ASTIGMATISM H7_ANISOMETROPIA H7_PRESBYOPIA H7_ACCOMMODIS H7_REFRADISNAS	16253
6. Filter based on genotype QC (FinnGen only)	14522

Control definitions (FinnGen only)

Control exclude: H7_OCUMUSCLE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H49-H52
Name in latin: Perturbationes refractionis et accommodationis (oculi)

NAME	H7_REFRAACCOMMODIS
CONTROL_EXCLUDE	H7_OCUMUSCLE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	H7_HYPERMETRO\|H7_MYOPIA\|H7_ASTIGMATISM\|H7_ANISOMETROPIA\|H7_PRESBYOPIA\|H7_ACCOMMODIS\|H7_REFRADISNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H52
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H52
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of refraction and accommodation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	129024	71773	56859
Only index persons	107279	60800	46479
Unadjusted period prevalence (%)
Whole population	1.84	2.06	1.59
Only index persons	2.04	2.24	1.77
Median age at first event (years)
Whole population	16.51	19.23	12.93
Only index persons	25.00	29.26	19.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	14522	9600	4922
Unadjusted period prevalence (%)	3.02	3.41	2.26
Median age at first event (years)	49.80	47.96	53.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
15194: Matched controls
151319

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H50.0

ICD-10 Finland

Convergent concomitant strabismus

351.9

311.2

314

CGD20

NOMESCO Finland

Laser-assisted in situ keratomileusis

417.9

307.7

643

H52.4

ICD-10 Finland

Presbyopia

24.3

307.7

3468

1823

H50.31

ICD-10 Finland

Intermittent exotropia

117.9

307.7

279

H50.30

ICD-10 Finland

Intermittent esotropy

148.2

307.7

220

Z96.1

ICD-10 Finland

Presence of intraocular lens

3.3

307.7

2067

6945

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

2.1

307.7

4637

26457

H50.52

ICD-10 Finland

Exophoria

28.3

307.7

356

128

H52.5

ICD-10 Finland

Disorders of accommodation

93.3

307.7

303

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

2.7

307.7

3958

17641

H52.1

ICD-10 Finland

Myopia

74.1

307.7

6348

1452

H50.1

ICD-10 Finland

Divergent concomitant strabismus

180.1

307.7

214

H53.0

ICD-10 Finland

Amblyopia ex anopsia

17.8

307.7

518

300

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.4

307.7

7044

40063

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.3

307.7

3193

15410

XCW99

NOMESCO Finland

Other investigative procedure of eye

3.2

307.7

1963

6673

H52.0

ICD-10 Finland

Hypermetropia

75.0

307.7

3161

528

H52.2

ICD-10 Finland

Astigmatism

69.3

307.7

2779

487

CGD10

NOMESCO Finland

Laser keratoplasty for error of refraction

105.3

307.7

531

H52.3

ICD-10 Finland

Anisometropia and aniseikonia

78.5

307.7

1159

159

XCK00

NOMESCO Finland

Perimetry

3.5

302.8

1089

3223

H50.2

ICD-10 Finland

Vertical strabismus

53.5

261.1

149

H26.4

ICD-10 Finland

After-cataract

2.8

229.3

1275

4846

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.6

221.4

1459

6033

H53.2

ICD-10 Finland

Diplopia

4.4

218.6

560

1297

H50.51

ICD-10 Finland

Esophoria

28.2

212.1

143

CEC10

NOMESCO Finland

Recession and resection of extraocular muscle

413.6

205.4

206

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.9

205.1

1058

3858

H25.0

ICD-10 Finland

Senile incipient cataract

3.0

197.8

930

3221

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

195.9

2059

10375

H44.2

ICD-10 Finland

Degenerative myopia

25.3

165.7

116

37002

ICD-8 Finland

Refractive errors, Myopia

+∞

160.4

154

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

158.4

1238

5503

H40.0

ICD-10 Finland

Glaucoma suspect

2.4

151.3

1149

5040

CG2T4

NOMESCO Finland

Topography assessment of cornea

6.7

151.1

242

366

H25.1

ICD-10 Finland

Senile nuclear cataract

1.8

149.0

2497

14660

ZXA10

NOMESCO Finland

Bilateral

1.8

146.5

2461

14452

37300

ICD-8 Finland

Strabismus, Concomitans convergens

+∞

144.8

139

37301

ICD-8 Finland

Strabismus, Concomitans divergens

+∞

137.5

132

H33.0

ICD-10 Finland

Retinal detachment with retinal break

3.6

131.4

441

1239

37001

ICD-8 Finland

Refractive errors, Hypermetropia. Hyperopia

+∞

129.1

124

H52

ICD-10 Finland

Disorders of refraction and accommodation

11.0

122.4

131

120

CJE40

NOMESCO Finland

Phakoemulsification with implantation of skleralt fixed artificial lens in posterior chamber

56.7

120.2

H26.02

ICD-10 Finland

Presenil cataract

3.3

116.0

461

1442

WX100

NOMESCO Finland

Conjunctival surface anesthesia

2.0

105.5

1263

6596

CG2X4

NOMESCO Finland

Optical coherence tomography (OCT) of cornea

7.2

100.6

149

207

CS5Z4

NOMESCO Finland

Specialised imaging for glaucoma

3.3

96.5

371

1137

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.2

92.1

843

3977

3671A

ICD-9 Finland

Disorders of refraction and accommodation, Myopia

+∞

91.6

CGD99

NOMESCO Finland

Other operation for error of refraction

45.0

90.9

H18.6

ICD-10 Finland

Keratoconus

5.9

90.4

163

278

WX140

NOMESCO Finland

Parabulbar anesthesy

2.6

89.5

545

2149

37000

ICD-8 Finland

Refractive errors, Astigmatismus

+∞

89.5

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

88.0

1093

5769

CEC00

NOMESCO Finland

Recession of extraocular muscle

860.2

87.6

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

85.0

1255

7006

H51.1

ICD-10 Finland

Convergence insufficiency and excess

112.7

82.8

S01ED51

ATC

timolol, combinations; ophthalmic

2.1

79.5

765

3677

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.8

77.2

1164

6533

H50.9

ICD-10 Finland

Strabismus, unspecified

14.3

77.1

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

3.8

76.9

233

610

H35.4

ICD-10 Finland

Peripheral retinal degeneration

5.0

76.5

164

328

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

2.6

76.3

446

1724

R51.80

ICD-10 Finland

Headache

1.5

76.1

2507

17240

H33.3

ICD-10 Finland

Retinal breaks without detachment

2.5

72.7

482

1978

Z94.7

ICD-10 Finland

Corneal transplant status

7.8

72.6

100

128

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

69.0

1330

8011

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.8

67.8

1154

6710

114

Kela drug reimbursment

Glaucoma

2.0

67.5

775

3973

Z3229

NOMESCO Finland

Other healthcare associate professional

1.8

67.4

1022

5739

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

140.1

65.8

H54.7

ICD-10 Finland

Unspecified visual loss

4.7

65.3

153

330

CJE99

NOMESCO Finland

Other extracapsular cataract operation using phakoemulsification technique

17.9

64.3

37303

ICD-8 Finland

Strabismus, Heterophoria (exophoria, esophroria, hypophoria)

+∞

63.5

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

6.7

62.6

148

CKC12

NOMESCO Finland

Photocoagulation of retina

2.2

62.2

541

2496

3503

FHL

Single muscle retroposition

608.3

61.7

XCH00

NOMESCO Finland

Eye pressure measurement

2.1

61.1

566

2678

H35.39

ICD-10 Finland

Degeneration of macula and posterior pole

2.7

60.7

321

1179

37720

ICD-8 Finland

Other diseases of retina and optic nerve, Amblyopia

23.9

59.9

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

7.0

59.6

131

R42

ICD-10 Finland

Dizziness and giddiness

1.4

59.4

2717

19847

CHC05

NOMESCO Finland

Iridotomy

3.5

58.5

200

569

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.8

58.1

294

1055

S01EE01

ATC

latanoprost; ophthalmic

2.1

58.1

575

2790

H40.13

ICD-10 Finland

Chronic glaucoma with open ventricular angle

2.3

56.8

444

1960

P85

ICPC

Mental retardation

6.5

56.8

141

CGG45

NOMESCO Finland

Full thickness transplantation of cornea using homograft

10.5

54.7

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

142.5

53.8

H35.38

ICD-10 Finland

Preretinal fibrosis of the macula

2.4

53.1

378

1602

XA800

NOMESCO Finland

Neuropsychological investigation

2.0

52.9

628

3254

H26.2

ICD-10 Finland

Complicated cataract

3.5

52.8

186

540

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

50.5

2947

22382

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.0

48.9

521

2597

H17.8

ICD-10 Finland

Other corneal scars and opacities

6.7

48.8

115

Z3231

NOMESCO Finland

Registered nurse

1.4

48.0

3363

26263

E0000UV, ,

ATC

1.3

46.4

5804

49066

S01BA07

ATC

fluorometholone; ophthalmic

2.9

45.9

220

768

AA1AD

NOMESCO Finland

CT of head and brain

1.4

45.6

2971

22917

ZXA00

NOMESCO Finland

Right side

1.4

44.8

2736

20881

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

44.1

1470

10046

H43.3

ICD-10 Finland

Other vitreous opacities

2.8

44.1

220

785

CJF10

NOMESCO Finland

Secondary implantation of artificial lens in posterior chamber

13.1

44.0

A06AC01

ATC

ispaghula (psylla seeds); oral

1.4

43.8

2989

23198

H25.8

ICD-10 Finland

Other senile cataract

1.7

43.5

856

5165

S01EC01

ATC

acetazolamide; systemic

2.7

43.5

243

919

CHD00

NOMESCO Finland

Laser trabeculoplasty

3.8

43.1

129

336

H53.4

ICD-10 Finland

Visual field defects

2.6

43.0

243

925

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

42.8

870

5295

H40.11

ICD-10 Finland

Low pressure glaucoma

2.8

42.7

209

738

ZXE00

NOMESCO Finland

One hour or less

1.3

42.4

4865

40545

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

42.4

5422

45809

N03AX12

ATC

[U] gabapentin; oral

1.4

42.1

1830

13163

S01EE05

ATC

tafluprost; ophthalmic

2.2

41.8

340

1527

S01EA05

ATC

brimonidine; ophthalmic

2.7

41.6

230

866

ZXD20

NOMESCO Finland

Day surgery

1.5

41.0

1506

10489

TAB00

NOMESCO Finland

Lumbar puncture

1.8

40.7

589

3253

S01EC04

ATC

brinzolamide; ophthalmic

2.2

40.1

346

1593

3507

FHL

Retroposition and resection

204.7

39.8

CS494

NOMESCO Finland

Other visual field testing

2.4

39.7

284

1208

ZXA05

NOMESCO Finland

Left side

1.4

39.1

2483

19020

F83

ICD-10 Finland

Mixed specific developmental disorders

3.3

39.1

147

446

Z2445

NOMESCO Finland

Psychologist

1.8

38.6

642

3696

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

2.3

38.5

281

1206

F29

ICPC

Eye symptom/complaint other

1.5

38.4

1439

10055

WX142

NOMESCO Finland

Sub-tenon anesthesy

4.2

38.1

101

241

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.0

37.9

412

2069

Z31.5

ICD-10 Finland

Genetic counselling

1.6

37.8

821

5079

CEC60

NOMESCO Finland

Transposition of extraocular muscle with adjustable suture

+∞

37.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

37.3

4080

33675

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

9.8

37.2

CHD05

NOMESCO Finland

Selective lasertrabeculoplasty

2.2

37.0

324

1500

Z2221

NOMESCO Finland

Medical doctor

1.3

37.0

3367

27131

N06AX21

ATC

duloxetine; oral

1.4

37.0

1535

10932

S01ED01

ATC

timolol; ophthalmic

2.3

36.9

296

1322

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

36.7

2804

22054

G44.2

ICD-10 Finland

Tension-type headache

1.4

36.6

1875

13857

H53.3

ICD-10 Finland

Other disorders of binocular vision

4.7

36.5

179

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

4.4

35.6

203

R62.0

ICD-10 Finland

Delayed milestone

3.3

35.2

133

405

N03AX11

ATC

topiramate; oral

2.0

35.1

370

1838

CEC30

NOMESCO Finland

Resection of extraocular muscle

346.7

34.9

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

5.7

34.7

112

A02BC05

ATC

esomeprazole; systemic

1.3

34.7

4863

41271

N03AX09

ATC

lamotrigine; oral

1.7

34.5

714

4362

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

2.7

34.4

180

659

H02AB09

ATC

hydrocortisone; systemic

2.1

34.3

338

1638

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

2.5

34.0

222

907

CS1H4

NOMESCO Finland

Retinal nerve fibre layer imaging

2.4

34.0

225

925

WX002

NOMESCO Finland

Sedation and analgesia

1.4

33.9

2011

15210

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.7

33.5

680

4133

N06AX11

ATC

mirtazapine; oral

1.3

33.5

4290

35990

3780A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONCOMITANS CONVERGENS]

+∞

33.3

TCG10

NOMESCO Finland

Removal of sutures from cornea

4.8

33.1

154

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

33.0

3064

24702

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

32.9

1646

12106

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.5

32.8

111

315

N03AG01

ATC

valproic acid; systemic, rectal

1.6

32.7

716

4437

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

32.3

1483

10741

UDC00

NOMESCO Finland

Ear microscopy

1.6

32.3

886

5795

3670A

ICD-9 Finland

Disorders of refraction and accommodation, Hypermetropia

+∞

32.2

J02AC01

ATC

fluconazole; systemic

1.2

32.1

5275

45456

R06AX27

ATC

desloratadine; oral

1.3

32.1

4265

35897

H18.5

ICD-10 Finland

Hereditary corneal dystrophies

3.1

32.0

130

414

H57.1

ICD-10 Finland

Ocular pain

1.7

31.8

552

3216

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

2.7

31.7

175

659

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

31.7

3165

25734

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

164.7

31.6

H35.30

ICD-10 Finland

Kuhnt-Junius degeneration

1.9

31.5

420

2261

H47.2

ICD-10 Finland

Optic atrophy

4.6

31.4

161

H54.2

ICD-10 Finland

Moderate visual impairment, binocular

3.7

31.3

100

273

G47.3

ICD-10 Finland

Sleep apnoea

1.3

31.2

2683

21386

N05BA01

ATC

diazepam; systemic, rectal

1.4

31.1

1383

9958

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

30.9

599

3599

F05

ICPC

Visual disturbance other

1.9

30.4

405

2180

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

30.2

1766

13307

M79.6

ICD-10 Finland

Pain in limb

1.2

30.2

5822

50916

WX402

NOMESCO Finland

General anaesthesia

1.3

30.2

2905

23490

3782B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Intermittent heterotropia[STRABISMUS DIVERGENS INTERMITTENS]

+∞

30.2

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.4

30.1

1545

11398

K07.60

ICD-10 Finland

Snapping jaw

1.6

30.1

756

4845

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

29.9

3079

25100

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

29.9

805

5242

RL140, ,

NOMESCO Finland

6.1

29.8

H50.8

ICD-10 Finland

Other specified strabismus

28.5

29.7

183

Kela drug reimbursment

Lamotrigin and topiramate

2.8

29.6

150

541

H54.5

ICD-10 Finland

Severe visual impairment, monocular

4.1

29.4

195

A02BC03

ATC

lansoprazole; oral

1.3

29.3

2984

24284

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.5

29.3

1092

7608

R53

ICD-10 Finland

Malaise and fatigue

1.3

29.1

3227

26532

602

Kela drug reimbursment

Children's severe malnutrition

3.6

29.1

259

TCG30

NOMESCO Finland

Imaging of anterior and posterior part of cornea

8.2

28.9

R01AD09

ATC

mometasone; nasal

1.2

28.9

6249

55204

XKC03

NOMESCO Finland

Water cystometry

2.0

28.9

305

1518

N02AX02

ATC

tramadol; systemic, rectal

1.2

28.7

4958

42807

N03AX16

ATC

[U] pregabalin

1.3

28.7

2492

19869

G40.9

ICD-10 Finland

Epilepsy, unspecified

1.9

28.6

372

1989

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

28.2

931

6330

3780B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Convergent concomitant strabismus[STRABISMUS CONVERGENS ALTERNANS]

+∞

28.1

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.4

28.0

101

299

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

28.0

1498

11123

Z2446

NOMESCO Finland

Social worker

1.5

28.0

838

5583

R03AC02

ATC

salbutamol; inhalant

1.2

27.9

7535

67919

N05CF01

ATC

zopiclone; oral

1.3

27.8

3379

28067

N05CF02

ATC

zolpidem; oral

1.3

27.7

2048

15964

H02.4

ICD-10 Finland

Ptosis of eyelid

2.0

27.7

302

1520

C07AA05

ATC

propranolol; systemic

1.3

27.6

2598

20922

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

27.5

3386

28157

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

27.5

2003

15585

H01AC01

ATC

somatropin; parenteral

3.6

27.4

251

H35.5

ICD-10 Finland

Hereditary retinal dystrophy

4.6

27.3

139

N03AX14

ATC

levetiracetam; systemic

1.9

27.2

331

1732

XKD00

NOMESCO Finland

Uroflowmetry

1.4

27.1

1194

8575

UKC02

NOMESCO Finland

Cystoscopy

1.4

27.1

1346

9870

CEW99

NOMESCO Finland

Other operation on extraocular muscle

+∞

27.0

CKD92

NOMESCO Finland

Combined vitrectomy and retinal procedure

2.8

26.9

136

490

A98

ICPC

Health maint/preventive medicine

1.7

26.9

14729

143659

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

3.2

26.8

106

333

Q87.4

ICD-10 Finland

Marfan syndrome

7.7

26.6

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

26.6

1724

13183

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

26.6

2455

19711

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

26.5

673

4324

H02AB06

ATC

prednisolone; systemic

1.2

26.4

5748

50659

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

26.4

4999

43466

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.5

26.0

159

631

N06AX16

ATC

venlafaxine; oral

1.3

25.7

1880

14624

F95

ICPC

Strabismus

9.1

25.5

G04BD12

ATC

mirabegron; oral

1.4

25.3

1060

7542

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.4

25.1

1198

8724

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

25.1

3615

30538

Z3226

NOMESCO Finland

Physiotherapist

1.3

25.0

2002

15762

R01AD12

ATC

fluticasone furoate; nasal

1.2

25.0

4487

38760

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

1.7

25.0

444

2606

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

25.0

4293

36923

3781B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS DIVERGENS ALTERNANS]

+∞

25.0

3680A

ICD-9 Finland

Visual disturbances, Amblyopia ex anopsia

57.9

24.9

R35

ICD-10 Finland

Polyuria

1.6

24.9

651

4210

G35

ICD-10 Finland

Multiple sclerosis

2.2

24.8

218

1013

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

2.0

24.7

261

1300

R06.0

ICD-10 Finland

Dyspnoea

1.3

24.7

2949

24397

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.3

24.6

1607

12294

XCD00

NOMESCO Finland

Clinical examination of eye in general anaesthesia

7.7

24.5

CKC60

NOMESCO Finland

Local buckling of sclera using implant

4.1

24.3

165

CKC30

NOMESCO Finland

Cryopexy of detached retina

4.1

24.2

157

M25.5

ICD-10 Finland

Pain in joint

1.2

24.2

4353

37588

N05AH04

ATC

quetiapine; oral

1.3

23.9

2298

18517

S01BA04

ATC

prednisolone; ophthalmic

2.2

23.9

207

957

R01AD58

ATC

fluticasone, combinations; nasal

1.2

23.9

3597

30497

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.7

23.9

458

2745

R4120

NOMESCO Finland

Occupational therapy

1.5

23.8

740

4967

H16.0

ICD-10 Finland

Corneal ulcer

1.6

23.7

598

3837

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

23.7

1084

7836

F43

ICPC

Eye, Other diagnostic procedure

2.1

23.6

232

1126

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

1.7

23.6

441

2625

N05BA09

ATC

clobazam; oral

2.9

23.6

109

375

N02BF01

ATC

gabapentin; oral

1.4

23.6

1181

8668

H17.1

ICD-10 Finland

Other central corneal opacity

5.7

23.5

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

23.5

1138

8306

N06AB04

ATC

citalopram; systemic

1.3

23.3

2314

18716

G43.9

ICD-10 Finland

Migraine, unspecified

1.4

23.2

925

6523

H02.3

ICD-10 Finland

Blepharochalasis

1.6

23.1

605

3913

H33.5

ICD-10 Finland

Other retinal detachments

3.0

23.1

102

342

G04CA01

ATC

alfuzosin; oral

1.4

23.0

907

6383

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.4

22.9

919

6485

3672A

ICD-9 Finland

Disorders of refraction and accommodation, Astigmatism

+∞

22.9

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

22.9

3350

28300

L17

ICPC

Foot/toe symptom/complaint

1.2

22.8

3820

32712

CKD91

NOMESCO Finland

Extended vitrectomy through pars plana

2.6

22.6

130

501

CKD93

NOMESCO Finland

Extended combined procedure on vitreous body and retina

4.0

22.6

157

H53.8

ICD-10 Finland

Other visual disturbances

2.3

22.4

169

738

H18.7

ICD-10 Finland

Other corneal deformities

7.7

22.4

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

22.4

973

6968

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.4

22.3

915

6483

J01FA10

ATC

azithromycin; systemic

1.2

22.3

8314

76438

R4110

NOMESCO Finland

Physiotherapy

1.2

22.2

3141

26422

N03AE01

ATC

clonazepam; systemic

1.6

22.2

585

3790

S01EA03

ATC

apraclonidine; ophthalmic

3.0

22.2

313

N03AF02

ATC

oxcarbazepine; oral

1.7

22.1

379

2204

TCW99

NOMESCO Finland

Other minor procedure in eye surgery

2.6

21.9

130

509

N02BE01

ATC

paracetamol; systemic, rectal

1.2

21.9

12374

118029

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

21.9

4962

43684

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.3

21.9

1838

14549

3781A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Divergent concomitant strabismus[STRABISMUS CONCOMITANS DIVERGENS]

+∞

21.8

H27.8

ICD-10 Finland

Other specified disorders of lens

6.2

21.7

SPAT1260

SPAT

Consultation of another employee

1.3

21.5

1954

15622

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.0

21.3

241

1232

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

7.8

21.1

A02BC02

ATC

pantoprazole; systemic

1.2

21.0

8480

78294

SPAT1263

SPAT

Sampling

1.2

20.9

5262

46704

WX199

NOMESCO Finland

Other local analgesia

1.8

20.8

325

1840

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

2.3

20.8

148

631

M03BX02

ATC

tizanidine; oral

1.2

20.8

8185

75375

UJF32

NOMESCO Finland

Coloscopy

1.2

20.7

2634

21889

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

20.5

2324

19061

3504

FHL

Retroposition of two muscles

209.4

20.5

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.5

20.5

580

3818

G43.3

ICD-10 Finland

Complicated migraine

1.9

20.5

260

1381

CKD40

NOMESCO Finland

Endophotocoagulation of retina

2.4

20.4

138

575

S01EE03

ATC

bimatoprost; ophthalmic

2.2

20.4

179

833

H40.10

ICD-10 Finland

Capsular glaucoma with pseudoexfoliation on the anterior lens capsule

2.1

20.3

180

841

H03AA01

ATC

levothyroxine sodium; systemic

1.2

20.3

2594

21566

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

20.2

2325

19102

A02BA02

ATC

ranitidine; systemic

1.3

19.9

1737

13802

H26.9

ICD-10 Finland

Cataract, unspecified

2.3

19.9

154

681

CHD35

NOMESCO Finland

Laser goniopuncture

4.1

19.8

128

CE2W4

NOMESCO Finland

Eye movement mapping

7.5

19.8

SMILE, ,

NOMESCO Finland

+∞

19.8

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

19.7

3879

33641

R03DC03

ATC

montelukast; oral

1.3

19.7

2085

16962

S01BC03

ATC

diclofenac; ophthalmic

2.0

19.7

211

1059

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

19.5

860

6171

R06AE07

ATC

cetirizine; oral

1.2

19.5

5911

53193

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

19.4

5565

49835

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.2

19.4

2990

25327

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

19.4

1381

10682

H93.1

ICD-10 Finland

Tinnitus

1.4

19.4

763

5367

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

19.4

841

6021

S01EC54

ATC

brinzolamide, combinations; ophthalmic

2.6

19.4

113

440

R55

ICD-10 Finland

Syncope and collapse

1.4

19.3

1040

7719

M41.4

ICD-10 Finland

Neuromuscular scoliosis

6.1

19.2

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

19.2

786

5567

J01MA02

ATC

ciprofloxacin; systemic

1.2

19.1

4153

36321

R13

ICD-10 Finland

Dysphagia

1.5

19.1

674

4644

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

19.1

1118

8405

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.3

19.1

1253

9581

L04AX01

ATC

azathioprine; systemic

1.6

19.1

489

3150

S01FA01

ATC

atropine; ophthalmic

4.0

19.0

132

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

19.0

2832

23899

J05AB01

ATC

aciclovir; systemic

1.2

19.0

2535

21150

CG2Z4

NOMESCO Finland

Specialised imaging of cornea

5.8

19.0

CHW99

NOMESCO Finland

Other operation on anterior chamber, anterior chamber angle, iris or ciliary body

18.1

19.0

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

6.7

19.0

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

19.0

1116

8394

S01EE04

ATC

travoprost; ophthalmic

2.2

18.9

151

677

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

2.9

18.9

294

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

3.2

18.9

237

R51

ICD-10 Finland

Headache

1.4

18.8

776

5507

A02BC01

ATC

omeprazole; systemic

1.2

18.8

2901

24571

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

18.7

923

6753

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

3.1

18.7

254

R02

ICPC

Shortness of breath/dyspnoea

1.3

18.7

1471

11534

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.6

18.6

484

3127

CKD10

NOMESCO Finland

Insufflation of vitreous cavity

2.2

18.6

161

746

S01AX11

ATC

[U] ofloxacin

1.8

18.6

303

1739

H46

ICD-10 Finland

Optic neuritis

2.4

18.5

121

497

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.5

18.5

497

3235

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

18.4

618

4216

C09CA06

ATC

candesartan; oral

1.2

18.4

2675

22512

ZY010

NOMESCO Finland

Hospital outpatient

1.4

18.3

715

5021

N06AA09

ATC

amitriptyline; systemic

1.4

18.3

857

6215

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

18.2

967

7158

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

18.2

983

7298

Q12.0

ICD-10 Finland

Congenital cataract

6.6

18.2

H26.3

ICD-10 Finland

Drug-induced cataract

3.0

18.1

259

WX400

NOMESCO Finland

Inhalation anesthesy

1.5

18.0

504

3310

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.2

18.0

3569

30926

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

18.0

2245

18588

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

18.0

2172

17920

H54.3

ICD-10 Finland

Mild or no visual impairment, binocular

4.1

18.0

116

R05

ICD-10 Finland

Cough

1.2

18.0

2614

21995

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

2.3

17.9

135

591

M03BX01

ATC

baclofen; systemic

2.0

17.9

202

1033

L03AX13

ATC

glatiramer acetate; parenteral

3.0

17.9

250

RT274, ,

NOMESCO Finland

4.9

17.9

H16.9

ICD-10 Finland

Keratitis, unspecified

1.9

17.9

207

1068

109

Kela drug reimbursment

Multiple sclerosis

2.1

17.8

157

734

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

17.8

720

5092

CS3P4

NOMESCO Finland

Optic nerve head stereophotography

2.6

17.7

101

389

ZXE20

NOMESCO Finland

More than three and less than five hours

1.3

17.7

1265

9786

CEC20

NOMESCO Finland

Recession and advancement of extraocular muscle

+∞

17.7

3783A

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Other and unspecified heterotropia

+∞

17.7

181

Kela drug reimbursment

Retigabine and vigabatrin

5.9

17.6

N03AG04

ATC

vigabatrin; oral

5.3

17.6

DFF20

NOMESCO Finland

Audiometry for children

3.7

17.6

149

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.2

17.6

5185

46433

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

1.9

17.6

218

1151

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.3

17.5

133

584

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.2

17.5

3351

28934

CJA00

NOMESCO Finland

Implantation of phakic lens in anterior chamber

179.5

17.5

AA5HE

NOMESCO Finland

Brain ultrasound examination in a child

3.1

17.3

239

K59.0

ICD-10 Finland

Constipation

1.5

17.3

564

3825

R06.5

ICD-10 Finland

Mouth breathing

1.3

17.3

1019

7665

D07AC01

ATC

betamethasone; topical

1.2

17.3

4284

37817

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

17.3

840

6131

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.5

17.3

588

4024

H27.1

ICD-10 Finland

Dislocation of lens

4.2

17.0

108

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

17.0

7890

73060

RT490, ,

NOMESCO Finland

6.6

16.9

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

16.9

7244

66672

F45.8

ICD-10 Finland

Other somatoform disorders

1.4

16.9

947

7071

J45

ICD-10 Finland

Asthma

1.3

16.9

1256

9770

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

5.9

16.8

M54.5

ICD-10 Finland

Low back pain

1.2

16.8

4723

42094

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

16.8

589

4053

37929

ICD-8 Finland

Blindness, one eye, specifically defined

19.2

16.8

R03BA05

ATC

fluticasone; inhalant

1.2

16.8

2232

18597

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.4

16.6

658

4633

CG2S4

NOMESCO Finland

Photography of cornea

3.8

16.6

132

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.8

16.6

257

1455

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

2.6

16.5

340

M79.1

ICD-10 Finland

Myalgia

1.2

16.4

1874

15358

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

16.3

2638

22401

C01CA24

ATC

epinephrine; parenteral

1.4

16.3

808

5918

3610A

ICD-9 Finland

Retinal detachments and defects, Retinal detachment with retinal defect

4.8

16.2

N06BA04

ATC

methylphenidate; oral

1.5

16.2

584

4041

J01DB01

ATC

cefalexin; oral

1.2

16.2

11558

110338

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

16.2

1372

10855

WX001

NOMESCO Finland

Nonpharmacological sedation or pain relief

6.5

16.1

N05BA04

ATC

oxazepam; oral

1.2

16.1

3006

25874

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.3

16.0

1562

12566

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

16.0

848

6275

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.8

16.0

235

1310

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

16.0

1016

7729

H57.9

ICD-10 Finland

Disorder of eye and adnexa, unspecified

2.2

15.9

138

642

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

15.8

969

7331

101

Kela drug reimbursment

Anterior pituitary hypofunction

2.5

15.8

382

N17

ICPC

Vertigo/dizziness

1.3

15.8

1330

10510

FM2CE, ,

NOMESCO Finland

2.3

15.8

115

497

N02AJ06

ATC

codeine and paracetamol; systemic

1.2

15.7

5434

49144

BE00A, ,

NOMESCO Finland

15.6

3007

Kela drug reimbursment

Erenumab and fremanezumab

1.9

15.6

189

991

CEC50

NOMESCO Finland

Advancement of extraocular muscle

+∞

15.6

N02CC04

ATC

rizatriptan; oral

1.4

15.6

707

5100

H35.1

ICD-10 Finland

Retinopathy of prematurity

6.8

15.6

L82

ICD-10 Finland

Seborrhoeic keratosis

1.2

15.6

1877

15467

N04.80

ICD-10 Finland

Congenital nephrotic syndrome of the Finnish type

12.8

15.6

S18

ICPC

Laceration/cut

1.2

15.6

5497

49776

SPAT1153

SPAT

Removal of sutures

1.2

15.5

3177

27549

N06AX26

ATC

vortioxetine; oral

1.3

15.5

1015

7751

3716A

ICD-9 Finland

Corneal opacity and other disorders of cornea, Keratoconus

19.1

15.5

F51.0

ICD-10 Finland

Nonorganic insomnia

1.2

15.5

2306

19422

J01AA02

ATC

doxycycline; systemic

1.2

15.4

9835

92838

H51.8

ICD-10 Finland

Other specified disorders of binocular movement

159.5

15.4

R03BA08

ATC

ciclesonide; inhalant

1.3

15.4

962

7296

SPAT1301

SPAT

No procedures

1.2

15.4

3530

30903

K59.09

ICD-10 Finland

Constipation, unspecified

1.4

15.4

638

4532

H53

ICD-10 Finland

Visual disturbances

2.3

15.3

117

516

L04AD01

ATC

ciclosporin; systemic

1.8

15.3

209

1139

A06AD11

ATC

lactulose; oral

1.3

15.3

1193

9332

J01CA04

ATC

amoxicillin; systemic

1.2

15.2

11942

114473

TCG40

NOMESCO Finland

Measurement of higher-grade errors of refraction

3.5

15.2

150

R50.9

ICD-10 Finland

Fever, unspecified

1.2

15.2

1800

14804

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.5

15.1

409

2669

R01AD01

ATC

beclometasone; nasal

1.2

15.1

1652

13467

XCW10

NOMESCO Finland

Assessment of vision

2.1

15.1

144

695

R01AD08

ATC

fluticasone; nasal

1.2

15.0

3514

30804

H50

ICD-10 Finland

Other strabismus

44.8

15.0

SAA04

NOMESCO Finland

Special examination of mouth

1.4

15.0

670

4821

H01

ICPC

Ear pain/earache

1.2

15.0

1676

13696

T85.2

ICD-10 Finland

Mechanical complication of intraocular lens

3.7

15.0

128

WX720

NOMESCO Finland

Own respiration

1.5

14.9

500

3415

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.4

14.9

605

4284

CD2S4

NOMESCO Finland

Photography of eye

2.8

14.8

256

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.8

14.8

212

1173

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

6.5

14.8

F28

ICPC

Limited function/disability (F)

2.7

14.8

284

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

14.8

1107

8613

J05AB11

ATC

valaciclovir; oral

1.2

14.8

1622

13224

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.4

14.8

656

4715

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.3

14.8

1026

7903

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.5

14.7

461

3104

WX110

NOMESCO Finland

Infiltration anesthesia

1.2

14.7

10229

96966

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.2

14.7

2468

21017

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.5

14.7

394

2568

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.3

14.7

875

6595

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.2

14.6

3893

34470

M79.7

ICD-10 Finland

Fibromyalgia

1.5

14.6

412

2715

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.2

14.6

2423

20611

3673A

ICD-9 Finland

Disorders of refraction and accommodation, Anisometropia and aniseikonia

+∞

14.6

H50.6

ICD-10 Finland

Mechanical strabismus

+∞

14.6

3505

FHL

Single muscle resection

+∞

14.6

CEC90

NOMESCO Finland

Total transposition of extraocular muscle or muscles

+∞

14.6

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.3

14.5

901

6828

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

5.3

14.5

CK2L4

NOMESCO Finland

Wide-field/panoramic imaging of ocular fundus

2.6

14.5

321

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.3

14.5

883

6674

G04BD08

ATC

solifenacin; oral

1.5

14.5

507

3491

WX780

NOMESCO Finland

Remote monitoring CPAP

1.5

14.4

479

3263

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

3.9

14.4

104

H01.80

ICD-10 Finland

Prolonged inflammation in the edge of the eyelid

2.3

14.4

108

473

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

14.4

3269

28569

N06AX12

ATC

bupropion; oral

1.3

14.4

1004

7736

U04

ICPC

Incontinence urine

1.5

14.4

466

3159

Z83.5

ICD-10 Finland

Family history of eye and ear disorders

4.0

14.4

100

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.4

14.4

382

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

14.3

1272

10114

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

14.3

1093

8528

TPH07

NOMESCO Finland

Cathetrisation of artery

1.3

14.3

1023

7913

3604

FHL

Penetration of the cornea

16.9

14.2

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

14.2

2135

17982

N06AB06

ATC

sertraline; oral

1.3

14.2

1439

11624

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

1.8

14.2

194

1059

M01AE03

ATC

ketoprofen; systemic, rectal

1.2

14.2

3817

33810

S06.0

ICD-10 Finland

Concussion

1.3

14.2

1252

9950

WX892

NOMESCO Finland

Monitored bed care

1.4

14.1

698

5108

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.1

14.1

5512

50176

M01AE02

ATC

naproxen; oral, rectal

1.1

14.0

7645

71150

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.3

14.0

1397

11263

H81

ICPC

Excessive ear wax

1.2

14.0

1587

12983

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.0

14.0

142

702

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

1.5

13.9

412

2743

WX702

NOMESCO Finland

Supraglottic ventilation device

1.4

13.9

614

4411

127

Kela drug reimbursment

Transplant complication

1.9

13.9

173

917

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

4.4

13.9

N02CC06

ATC

eletriptan; oral

1.5

13.8

455

3095

SPAT1325

SPAT

Vaccination

1.2

13.8

3543

31253

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.3

13.8

1153

9097

R52.2

ICD-10 Finland

Other chronic pain

1.5

13.8

389

2562

F84.5

ICD-10 Finland

Asperger syndrome

2.2

13.8

114

520

RL130, ,

NOMESCO Finland

3.4

13.8

145

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

3.5

13.7

131

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.4

13.6

519

3631

J45.9

ICD-10 Finland

Asthma, unspecified

1.2

13.6

2149

18179

N06AB10

ATC

escitalopram; oral

1.2

13.6

2734

23637

Z99.2

ICD-10 Finland

Dependence on renal dialysis

5.3

13.6

K59.1

ICD-10 Finland

Functional diarrhoea

1.4

13.5

582

4164

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.3

13.5

1104

8691

R1250

NOMESCO Finland

Evaluation of functional capability

1.7

13.5

242

1431

K30

ICD-10 Finland

Functional dyspepsia

1.3

13.4

1298

10427

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.3

13.4

1247

9975

XF600

NOMESCO Finland

Bloodpressure measurement

1.4

13.3

630

4578

L03

ICPC

Low back symptom/complaint

1.2

13.3

3686

32698

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.8

13.2

183

1004

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

1.8

13.2

195

1091

S01XA18

ATC

ciclosporin; ophthalmic

2.4

13.1

380

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.5

13.1

411

2770

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

13.1

886

6800

R03BA02

ATC

budesonide; inhalant

1.2

13.1

2076

17570

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

13.1

407

2740

H18.4

ICD-10 Finland

Corneal degeneration

2.9

13.0

213

Z87.6

ICD-10 Finland

Personal history of certain conditions arising in the perinatal period

2.3

13.0

406

N06AB05

ATC

paroxetine; oral

1.4

13.0

628

4582

301

Kela drug reimbursment

Growth hormone

3.7

12.9

108

R52.9

ICD-10 Finland

Pain, unspecified

1.3

12.9

1169

9317

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.4

12.9

535

3802

M54.6

ICD-10 Finland

Pain in thoracic spine

1.3

12.9

878

6745

R11

ICD-10 Finland

Nausea and vomiting

1.3

12.9

1004

7856

F01

ICPC

Eye pain

1.5

12.8

362

2387

S29

ICPC

Skin symptom/complaint other

1.2

12.8

2361

20248

L01

ICPC

Neck symptom/complaint

1.2

12.8

2022

17101

J01FA09

ATC

clarithromycin; systemic

1.2

12.8

3836

34208

R5210

NOMESCO Finland

Assessment of the improvements needed in the living environment

3.9

12.8

SPAT1310

SPAT

Counselling related to known health issue

1.2

12.7

3761

33501

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

11.5

12.7

XX4AW, ,

NOMESCO Finland

2.9

12.6

190

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

12.6

3568

31679

ZYC01

NOMESCO Finland

Remote contact by phone

1.3

12.6

712

5325

NH3EA

NOMESCO Finland

Feet X-ray examination with load

1.7

12.5

202

1160

N03AF01

ATC

carbamazepine; oral, rectal

1.5

12.5

418

2857

C07AB02

ATC

metoprolol; systemic

1.2

12.4

1549

12795

L04AA06

ATC

mycophenolic acid; systemic

1.7

12.4

208

1207

CKD60

NOMESCO Finland

Anterior vitrectomy

2.8

12.4

214

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.4

12.3

625

4596

N06AX05

ATC

trazodone; oral

1.6

12.3

261

1612

R03AK08

ATC

formoterol and beclometasone; inhalant

1.4

12.3

461

3218

N02CD01

ATC

erenumab; parenteral

2.1

12.2

119

580

H02AB04

ATC

methylprednisolone; systemic

1.2

12.2

1436

11789

37003

ICD-8 Finland

Refractive errors, Anisometropia

37.4

12.2

M48.0

ICD-10 Finland

Spinal stenosis

1.3

12.1

947

7409

A03FA02

ATC

cisapride; oral, rectal

1.4

12.1

631

4659

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

12.1

2389

20604

N02CC07

ATC

frovatriptan; oral

1.4

12.1

507

3611

WX704

NOMESCO Finland

Intubation

1.3

12.1

874

6770

H27.0

ICD-10 Finland

Aphakia

4.2

12.1

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

12.1

671

5005

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.4

12.1

590

4313

M54.4

ICD-10 Finland

Lumbago with sciatica

1.2

12.1

2096

17876

SPAT1249

SPAT

Treatment-related counselling outside office

1.1

12.1

4810

43713

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

1.7

12.0

232

1399

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.6

12.0

253

1561

H40.9

ICD-10 Finland

Glaucoma, unspecified

2.0

12.0

124

618

Q21.10

ICD-10 Finland

Persistent ostium secundum

2.4

12.0

328

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.2

12.0

1362

11140

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

12.0

3404

30216

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.5

11.9

326

2136

CA1CM

NOMESCO Finland

Eye and orbita extensive MRI examination with 3 Tesla magnet

4.1

11.9

H92.0

ICD-10 Finland

Otalgia

1.3

11.9

830

6397

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.3

11.9

727

5500

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.0

11.9

116

566

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1.5

11.9

389

2646

J01FF01

ATC

clindamycin; systemic

1.2

11.9

2986

26258

R4130

NOMESCO Finland

Speech therapy

1.6

11.8

247

1520

RK220, ,

NOMESCO Finland

3.0

11.8

165

X58

ICD-10 Finland

Exposure to other specified factors

1.2

11.8

1825

15395

H33.1

ICD-10 Finland

Retinoschisis and retinal cysts

2.7

11.8

225

G50.1

ICD-10 Finland

Atypical facial pain

1.8

11.8

182

1033

CJF30

NOMESCO Finland

Reduction of dislocation of artificial lens

4.5

11.8

Q10.0

ICD-10 Finland

Congenital ptosis

5.3

11.7

H61.2

ICD-10 Finland

Impacted cerumen

1.3

11.7

669

5012

R30.0

ICD-10 Finland

Dysuria

1.4

11.7

487

3466

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

11.7

3497

31147

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.3

11.6

884

6893

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.2

11.6

1403

11551

Z94.0

ICD-10 Finland

Kidney transplant status

2.0

11.6

119

592

N01

ICPC

Headache

1.2

11.6

1760

14824

SPAT1312

SPAT

General health counselling

1.1

11.6

4016

36136

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

11.6

1130

9087

Q99.8

ICD-10 Finland

Other specified chromosome abnormalities

4.4

11.6

H01.0

ICD-10 Finland

Blepharitis

1.3

11.6

846

6564

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.4

11.5

521

3760

ZYB02

NOMESCO Finland

Outreach service at unit of another specialty

2.5

11.5

274

XCD20

NOMESCO Finland

Photoangiography of eye

2.0

11.5

116

573

Z71.8

ICD-10 Finland

Other specified counselling

1.1

11.5

4548

41280

G03DB01

ATC

dydrogesterone; oral

1.2

11.5

1457

12055

Q85.1

ICD-10 Finland

Tuberous sclerosis

11.0

11.5

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.2

11.5

442

XF404

NOMESCO Finland

Ambulatory ECG

1.3

11.5

735

5600

OAB50, ,

SPAT

1.3

11.4

780

5994

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.2

11.4

1596

13334

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.4

11.4

564

4133

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

2.3

11.4

367

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.2

11.4

1560

13008

S01EC03

ATC

dorzolamide; ophthalmic

2.2

11.4

405

J20

ICD-10 Finland

Acute bronchitis

1.3

11.4

1165

9421

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

2.4

11.4

300

L04AX03

ATC

methotrexate; systemic

1.3

11.4

1024

8158

CJ2M4

NOMESCO Finland

Scans and measurement printouts for intraocular lens power calculation

2.3

11.3

349

M35.7

ICD-10 Finland

Hypermobility syndrome

1.7

11.3

188

1090

JN3AD

NOMESCO Finland

Abdominal CT examination

1.2

11.3

1307

10709

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

1.9

11.3

144

771

DFF00

NOMESCO Finland

Pure tone audiometry

1.3

11.3

914

7184

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.0

11.3

125

639

CGG99

NOMESCO Finland

Other reconstructive operations on cornea and sclera

10.5

11.2

J01FA06

ATC

roxithromycin; oral

1.1

11.2

4397

39880

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.3

11.2

674

5092

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.4

11.2

457

3244

SCD02

NOMESCO Finland

Removal of biofilm and/or supragingival calculus

2.2

11.2

383

L04AA31

ATC

[U] teriflunomide

3.1

11.1

150

M03AX01

ATC

botulinum toxin; parenteral

1.7

11.1

182

1051

3046, ,

Kela drug reimbursment

24.9

11.1

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.4

11.1

478

3423

CKC65

NOMESCO Finland

Removal of buckling implant from sclera

5.5

11.1

H52.7

ICD-10 Finland

Disorder of refraction, unspecified

5.5

11.1

353

Kela drug reimbursment

Cladribine and fingolimod

3.0

11.1

161

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.3

11.1

616

4597

L04AA01

ATC

[U] ciclosporin

1.9

11.1

129

671

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.1

11.1

4530

41187

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

2.4

11.1

310

R4110, ,

SPAT

1.2

11.0

1336

11002

N02CC03

ATC

zolmitriptan; nasal, oral

1.3

11.0

628

4706

G04CA02

ATC

tamsulosin; oral

1.2

10.9

1539

12868

H50.4

ICD-10 Finland

Other and unspecified heterotropia

43.2

10.9

L08

ICPC

Shoulder symptom/complaint

1.2

10.9

2555

22334

H40.22

ICD-10 Finland

Chronic glaucoma with closed ventricular angle

2.7

10.9

218

L03AB07

ATC

interferon beta-1a; parenteral

2.3

10.8

325

C08CA01

ATC

amlodipine; oral

1.1

10.8

3402

30379

M01AH01

ATC

celecoxib; oral

1.2

10.8

1668

14066

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

1.6

10.8

240

1502

H47.3

ICD-10 Finland

Other disorders of optic disc

2.9

10.8

169

N86

ICPC

Multiple sclerosis

2.3

10.8

326

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.4

10.8

411

2881

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.2

10.8

1451

12077

NA3BG, ,

SPAT

1.4

10.8

496

3593

CKD70

NOMESCO Finland

Excision of preretinal or epiretinal membrane

1.9

10.8

121

622

C05AA08

ATC

fluocortolone; rectal, topical

1.2

10.7

1267

10404

164

Kela drug reimbursment

Fingolimod

2.9

10.7

175

SPAT1097

SPAT

Recording of ECG

1.2

10.7

1200

9799

L03AB08

ATC

interferon beta-1b; parenteral

3.2

10.7

133

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

1.8

10.7

148

814

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.3

10.7

664

5038

A02BC04

ATC

rabeprazole; oral

1.3

10.7

906

7165

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.6

10.7

225

1390

WX723

NOMESCO Finland

CPAP therapy

1.4

10.7

447

3187

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

2.2

10.7

397

H47.1

ICD-10 Finland

Papilloedema, unspecified

2.4

10.6

285

E03

ICD-10 Finland

Other hypothyroidism

1.3

10.6

615

4618

XQ800

NOMESCO Finland

Prick test

1.3

10.6

913

7232

N99

ICPC

Neurological disease other

2.0

10.6

112

564

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

2.2

10.6

392

S01AD03

ATC

aciclovir; ophthalmic

1.5

10.6

316

2113

RS221, ,

NOMESCO Finland

1.8

10.6

147

810

CA1ME

NOMESCO Finland

Ultrasound oculometry

2.8

10.6

182

SPAT1211

SPAT

Application of soft bandage

1.3

10.5

896

7087

H02AB07

ATC

prednisone; oral

1.2

10.5

1243

10208

L57.0

ICD-10 Finland

Actinic keratosis

1.3

10.5

734

5662

CS2P4

NOMESCO Finland

Optic nerve head imaging

2.3

10.5

355

M01AH05

ATC

etoricoxib; oral

1.1

10.5

7963

75027

J34.2

ICD-10 Finland

Deviated nasal septum

1.4

10.5

519

3805

AA3AD

NOMESCO Finland

CT of face

2.2

10.5

387

37600

ICD-8 Finland

Detachment of retina, Primaria

8.4

10.5

S01EE51

ATC

latanoprost and netarsudil; ophthalmic

3.1

10.5

140

F84.9

ICD-10 Finland

Pervasive developmental disorder, unspecified

2.8

10.4

183

CJF50

NOMESCO Finland

Removal and implantation of artificial lens in posterior chamber

10.0

10.4

N03AX18

ATC

lacosamide; systemic

2.2

10.4

407

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

2.4

10.4

294

RT271, ,

NOMESCO Finland

3.6

10.4

3784B

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Heterophoria[EXOPHORIA]

+∞

10.4

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.4

10.4

427

3035

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

10.3

551

4087

F93.89

ICD-10 Finland

Other childhood emotional disorders

1.8

10.3

136

737

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

1.6

10.3

226

1410

RT190, ,

NOMESCO Finland

7.6

10.3

CKC70

NOMESCO Finland

Circular buckling of sclera

3.4

10.3

106

E000001, ,

ATC

1.2

10.3

2314

20149

N18.8

ICD-10 Finland

Other chronic renal failure

1.7

10.3

167

963

37103

ICD-8 Finland

Corneal opacity, Keratoconus

32.4

10.3

G40.10

ICD-10 Finland

Simple partial seizures

2.3

10.3

333

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

1.9

10.3

130

696

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

8.1

10.3

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

1.6

10.2

220

1367

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.3

10.2

645

4906

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

1.5

10.2

320

2161

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

2.3

10.2

334

H26.01

ICD-10 Finland

Infantile, juvenile and presenile cataract

4.3

10.2

N05AX12

ATC

aripiprazole; systemic

1.4

10.2

517

3807

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

2.2

10.1

373

R06AX22

ATC

ebastine; oral

1.2

10.1

1975

17000

Z01.9

ICD-10 Finland

Special examination, unspecified

1.3

10.1

591

4445

N06AB03

ATC

fluoxetine; oral

1.2

10.1

1334

11080

P06

ICPC

Sleep disturbance

1.2

10.1

1614

13654

K00.40

ICD-10 Finland

Postnatal enamel hypoplasia

1.8

10.1

141

779

N04BB01

ATC

amantadine; oral

1.9

10.0

131

708

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.5

10.0

329

2242

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

3.7

10.0

3744

FHL

Pericardial identification surgery with coagulation (includes epi- and intrascleral indications and eg Lincoff catheter)

5.2

10.0

H40.20

ICD-10 Finland

Acute glaucoma with closed ventricular angle

3.2

10.0

118

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.4

10.0

484

3536

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

10.0

929

7428

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.2

10.0

1059

8595

G43

ICD-10 Finland

Migraine

1.3

9.9

762

5953

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.2

9.9

1097

8948

RT150, ,

NOMESCO Finland

2.7

9.9

183

L04AD02

ATC

tacrolimus; systemic

1.9

9.9

120

634

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.7

9.9

160

923

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

9.9

1067

8681

P29

ICPC

Psychological sympt/compl other

1.2

9.8

1089

8886

CJA10

NOMESCO Finland

Implantation of phakic lens in posterior chamber

25.9

9.8

WZC00

NOMESCO Finland

Treatment plan or consultation

1.1

9.7

4733

43413

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.4

9.7

450

3265

M79.0

ICD-10 Finland

Rheumatism, unspecified

1.5

9.7

311

2111

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.2

9.7

2150

18698

H54.6

ICD-10 Finland

Moderate visual impairment, monocular

3.0

9.7

131

D07AA02

ATC

hydrocortisone; topical

1.2

9.7

1716

14652

H35.36

ICD-10 Finland

Macular cyst

2.4

9.6

280

D22

ICD-10 Finland

Melanocytic naevi

1.3

9.6

699

5420

B07.9

ICD-10 Finland

Verruca simplex

1.4

9.6

432

3118

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

2.2

9.6

330

TKC22

NOMESCO Finland

Catheterisation instruction

1.7

9.6

164

960

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.7

9.6

172

1020

R31

ICD-10 Finland

Unspecified haematuria

1.3

9.6

754

5906

N88

ICPC

Epilepsy

2.2

9.6

343

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

9.6

372

2618

H54.4

ICD-10 Finland

Blindness, monocular

3.6

9.6

N62

ICD-10 Finland

Hypertrophy of breast

1.4

9.6

449

3266

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

9.5

111

579

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.3

9.5

950

7660

R39.1

ICD-10 Finland

Other difficulties with micturition

1.5

9.5

250

1628

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.5

9.5

319

2185

XF402

NOMESCO Finland

ECG with work load test

1.3

9.5

811

6420

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.4

9.5

349

2432

R06.4

ICD-10 Finland

Hyperventilation

1.7

9.5

169

1001

EJC20

NOMESCO Finland

Operation on frenulum of tongue

2.5

9.5

216

SPAT1009

SPAT

Measurement of intraocular pressure

1.9

9.5

108

559

M54.2

ICD-10 Finland

Cervicalgia

1.3

9.5

886

7092

H02

ICPC

Hearing complaint

1.2

9.5

1217

10082

A04

ICPC

Weakness/tiredness general

1.2

9.4

1874

16151

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.3

9.4

775

6108

N07CA01

ATC

betahistine; oral

1.3

9.4

573

4339

R32

ICD-10 Finland

Unspecified urinary incontinence

1.6

9.4

222

1412

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.7

9.4

148

848

D07AC13

ATC

mometasone; topical

1.1

9.4

3194

28640

M02AA07

ATC

piroxicam; topical

1.1

9.4

3445

31046

S01GX08

ATC

ketotifen; ophthalmic

1.3

9.4

537

4030

3602A

ICD-9 Finland

Disorders of the globe, Degenerative disorders of globe[MYOPIA MALIGNA]

+∞

9.4

H50.3

ICD-10 Finland

Intermittent heterotropia

+∞

9.4

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.3

9.3

591

4498

CA1BG

NOMESCO Finland

Eye and orbita MRI examination with high intensity magnet

2.9

9.3

139

Congenital heart failure surgery

3.7

9.3

L20.0

ICD-10 Finland

Besnier prurigo

1.2

9.3

1063

8696

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.2

9.3

1130

9304

G93.2

ICD-10 Finland

Benign intracranial hypertension

2.9

9.3

150

J01MA06

ATC

norfloxacin; oral

1.2

9.3

1170

9670

N06AX17

ATC

milnacipran; oral

1.9

9.3

104

535

R15

ICD-10 Finland

Faecal incontinence

1.6

9.3

220

1400

K03.00

ICD-10 Finland

Approximal wear

1.3

9.3

899

7224

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.2

9.3

1001

8141

WYA10

NOMESCO Finland

Emergency care or similar visit

1.3

9.3

846

6751

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.2

9.3

1303

10888

XJH00

NOMESCO Finland

Transanal ultrasonography

1.4

9.3

335

2328

J01DA06

ATC

[U] cefuroxime

1.2

9.3

1459

12323

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

9.2

2590

22914

C10AC01

ATC

colestyramine; oral

1.5

9.2

257

1695

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.3

9.2

524

3926

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.2

9.2

2372

20853

CKD15

NOMESCO Finland

Injection of vitreous substitute

2.8

9.2

151

S01BC05

ATC

ketorolac; ophthalmic

1.6

9.2

230

1482

P01BA02

ATC

hydroxychloroquine; oral

1.3

9.2

787

6233

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

9.2

1456

12304

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.4

9.2

449

3288

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

9.2

2538

22433

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.3

9.2

816

6493

D01BA02

ATC

terbinafine; oral

1.2

9.2

2577

22805

L01BA01

ATC

methotrexate; systemic

1.4

9.1

325

2252

3619

FHL

Other operations in this group, such as corneal refractive surgery

13.6

9.1

H29

ICPC

Ear symptom/complaint other

1.2

9.1

1246

10382

J45.1

ICD-10 Finland

Nonallergic asthma

1.3

9.1

733

5760

B03XA01

ATC

erythropoietin; parenteral

2.3

9.1

306

J01AA07

ATC

tetracycline; systemic

1.2

9.1

1690

14479

D01

ICPC

Abdominal pain/cramps general

1.2

9.1

1614

13776

G50.0

ICD-10 Finland

Trigeminal neuralgia

1.7

9.1

167

998

R51.81

ICD-10 Finland

Facial pain NOS

1.5

9.1

248

1629

R00.2

ICD-10 Finland

Palpitations

1.2

9.1

905

7298

R03BA01

ATC

beclometasone; inhalant

1.2

9.1

1380

11619

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

9.1

2351

20682

D06

ICPC

Abdominal pain localized other

1.2

9.1

1087

8942

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

4.2

9.0

L04AA27

ATC

[U] fingolimod

3.1

9.0

121

L28

ICPC

Limited function/disability (L)

1.2

9.0

1616

13810

F79

ICD-10 Finland

Unspecified mental retardation

9.0

CGG11

NOMESCO Finland

Corneal cross-linking

3.7

9.0

RS110, ,

NOMESCO Finland

2.9

9.0

137

P07.2

ICD-10 Finland

Extreme immaturity

7.0

9.0

CFA20

NOMESCO Finland

Biopsy of conjunctiva

3.4

9.0

A97

ICPC

No disease

1.2

8.9

2391

21079

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.3

8.9

873

7023

R12

ICD-10 Finland

Heartburn

1.2

8.9

932

7553

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.4

8.9

314

2172

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.1

8.9

4581

42100

N05CD08

ATC

midazolam; nasal, systemic

1.6

8.9

182

1118

J47

ICD-10 Finland

Bronchiectasis

1.8

8.9

127

707

G04BD07

ATC

tolterodine; oral

1.4

8.9

315

2181

N02CC05

ATC

almotriptan; oral

1.4

8.9

460

3399

A28

ICPC

Limited function/disability NOS

1.2

8.9

1292

10830

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

1.6

8.9

186

1150

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.3

8.9

867

6975

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

1.7

8.8

140

804

J02AC02

ATC

itraconazole; systemic

1.2

8.8

1816

15693

BC00A, ,

NOMESCO Finland

7.9

8.8

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

2.7

8.8

172

KMAK, ,

NOMESCO Finland

1.1

8.8

6578

61694

A01

ICPC

Pain general/multiple sites

1.2

8.8

1023

8393

RS311, ,

NOMESCO Finland

3.0

8.7

123

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.3

8.7

513

3865

H26.8

ICD-10 Finland

Other specified cataract

2.1

8.7

364

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.3

8.7

556

4239

N02CD03

ATC

fremanezumab; systemic

1.8

8.7

123

683

H66.9

ICD-10 Finland

Otitis media, unspecified

1.2

8.7

970

7918

N30.0

ICD-10 Finland

Acute cystitis

1.2

8.7

1976

17207

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

1.5

8.7

301

2077

H35.6

ICD-10 Finland

Retinal haemorrhage

2.4

8.7

244

-1, ,

NOMESCO Finland

1.1

8.7

4502

41386

RT160, ,

NOMESCO Finland

3.0

8.6

124

N02BF02

ATC

pregabalin; oral

1.3

8.6

693

5448

SPAT1262

SPAT

Handing over of treatment supplies

1.2

8.6

1503

12810

R06AE09

ATC

levocetirizine; oral

1.2

8.6

1708

14716

G40.89

ICD-10 Finland

Other epilepsy

2.4

8.6

233

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.2

8.6

1015

8340

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.7

8.6

157

939

P01AB01

ATC

metronidazole; oral, rectal

1.1

8.6

4771

44026

C07AB07

ATC

bisoprolol; oral

1.1

8.5

4496

41355

J01MA12

ATC

levofloxacin; systemic

1.2

8.5

1637

14066

H40

ICD-10 Finland

Glaucoma

2.1

8.5

348

ZXD05

NOMESCO Finland

Urgent procedure

1.1

8.5

3291

29730

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

8.5

1393

11808

Q87.80

ICD-10 Finland

Alport syndrome

10.0

8.5

RS222, ,

NOMESCO Finland

1.9

8.5

106

567

ZXX03

NOMESCO Finland

Extent of procedure, 3 units

2.2

8.5

297

A11

ICPC

Chest pain NOS

1.3

8.4

781

6245

RS220, ,

NOMESCO Finland

1.8

8.4

129

734

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.3

8.4

737

5854

L13

ICPC

Hip symptom/complaint

1.2

8.4

1879

16338

J01EA01

ATC

trimethoprim; systemic

1.1

8.4

2773

24791

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

3.1

8.4

105

K08.80

ICD-10 Finland

Toothache NOS

1.2

8.4

1101

9140

N05AX08

ATC

risperidone; systemic

1.3

8.4

726

5760

Q25.0

ICD-10 Finland

Patent ductus arteriosus

2.8

8.4

148

G43.8

ICD-10 Finland

Other migraine

1.6

8.4

190

1199

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.6

8.4

168

1029

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

8.4

2105

18471

Q05.2

ICD-10 Finland

Lumbar spina bifida with hydrocephalus

12.7

8.3

3768

FHL

Eye examination under general anesthesia

12.7

8.3

37302

ICD-8 Finland

Strabismus, Concomitans sursum sive deorsum vergens

+∞

8.3

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

1.6

8.3

164

1000

L12

ICPC

Hand/finger symptom/complaint

1.2

8.3

2123

18648

XF602

NOMESCO Finland

Bloodpressure monitoring

1.8

8.3

107

578

SCA01

NOMESCO Finland

Preventive oral health care, short

1.1

8.3

4265

39163

E66.8

ICD-10 Finland

Other obesity

1.3

8.3

642

5023

Z93.1

ICD-10 Finland

Gastrostomy status

4.4

8.3

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.3

8.3

740

5894

E000006, ,

ATC

1.3

8.3

644

5043

Q87.09

ICD-10 Finland

Other congenital malformations that mainly affect the appearance of the face

8.5

8.3

H43.2

ICD-10 Finland

Crystalline deposits in vitreous body

3.3

8.3

NB1DG

NOMESCO Finland

Shoulder and humerus very extensive MRI examination with high intensity magnet

1.9

8.2

474

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.5

8.2

224

1472

W19

ICD-10 Finland

Unspecified fall

1.2

8.2

993

8173

P03

ICPC

Feeling depressed

1.2

8.2

1479

12635

N05BE01

ATC

buspirone; oral

1.5

8.2

271

1852

M08.9

ICD-10 Finland

Juvenile arthritis, unspecified

2.7

8.2

155

VALMI, ,

NOMESCO Finland

1.1

8.2

3230

29193

Z50.5

ICD-10 Finland

Speech therapy

1.7

8.2

150

896

M01AH02

ATC

rofecoxib; oral

1.2

8.2

991

8156

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

2.9

8.2

133

R60.9

ICD-10 Finland

Oedema, unspecified

1.3

8.2

496

3753

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

8.2

700

5543

R06AX13

ATC

loratadine; oral

1.2

8.2

1754

15199

N29

ICPC

Neurological sympt/complt other

1.6

8.2

165

1011

L04AA13

ATC

[U] leflunomide

1.5

8.2

218

1426

H50.50

ICD-10 Finland

Alternating hyperphoria

7.0

8.2

H18.9

ICD-10 Finland

Disorder of cornea, unspecified

3.8

8.2

D31.3

ICD-10 Finland

Benign neoplasm: Choroid

1.7

8.2

138

808

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.3

8.2

634

4964

H13

ICPC

Plugged feeling ear

1.2

8.1

1814

15771

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

1.6

8.1

177

1106

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.3

8.1

543

4168

R03AC03

ATC

terbutaline; inhalant

1.2

8.1

1461

12484

EG1CG

NOMESCO Finland

Extensive MRI examination of mandibular joint with high intensity magnet

2.5

8.1

191

-44

ICPC

Preventive immunization/medic

1.3

8.1

673

5315

CGF10

NOMESCO Finland

Suture of laceration of cornea

4.3

8.1

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.5

8.1

219

1439

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

3.9

8.1

EMB15

NOMESCO Finland

Partial tonsillectomy

3.0

8.1

113

A07DA03

ATC

loperamide; oral

1.5

8.0

242

1625

D06BX01

ATC

metronidazole; topical

1.2

8.0

1097

9144

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

1.6

8.0

168

1041

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.2

8.0

1522

13067

H51.9

ICD-10 Finland

Disorder of binocular movement, unspecified

21.9

8.0

1530, ,

Kela drug reimbursment

21.9

8.0

H52.6

ICD-10 Finland

Other disorders of refraction

21.9

8.0

RK110, ,

NOMESCO Finland

2.2

8.0

298

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.5

8.0

255

1734

G44.0

ICD-10 Finland

Cluster headache syndrome

1.8

8.0

119

673

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

8.0

1415

12078

C08CA05

ATC

nifedipine; systemic

1.3

7.9

435

3246

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.5

7.9

214

1405

SPAT1229

SPAT

Assessment of need for aid

1.3

7.9

535

4113

E21.2

ICD-10 Finland

Other hyperparathyroidism

2.7

7.9

147

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

1.8

7.9

106

580

H26.1

ICD-10 Finland

Traumatic cataract

2.9

7.9

125

L21.0

ICD-10 Finland

Seborrhoea capitis

1.8

7.9

105

573

CJB20

NOMESCO Finland

Irrigation and polishing of secondary cataract

7.2

7.9

L71

ICD-10 Finland

Rosacea

1.4

7.9

285

1983

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.2

7.9

1424

12169

Z94.4

ICD-10 Finland

Liver transplant status

2.6

7.9

176

N05CD07

ATC

temazepam; oral

1.2

7.9

810

6557

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

7.9

1185

9970

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.1

7.8

2188

19335

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

1.7

7.8

137

810

H50.59

ICD-10 Finland

Heterophor UNS

7.7

7.8

H19.1*B00.5

ICD-10 Finland

Herpesviral keratoconjunctivitis

2.0

7.8

407

G45.3

ICD-10 Finland

Amaurosis fugax

1.7

7.8

132

773

M54.1

ICD-10 Finland

Radiculopathy

1.4

7.8

376

2751

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.3

7.8

675

5357

H60

ICD-10 Finland

Otitis externa

1.3

7.8

598

4676

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.6

7.8

193

1244

JDB00

NOMESCO Finland

Gastrostomy

3.6

7.8

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

1.7

7.8

121

693

WX882

NOMESCO Finland

High dependency care

1.4

7.8

272

1883

ZX199

NOMESCO Finland

Other rote

3.1

7.7

100

R52.0

ICD-10 Finland

Acute pain

1.4

7.7

346

2501

NG1DA

NOMESCO Finland

X-ray of knees

1.6

7.7

152

927

D07AD01

ATC

clobetasol; topical

1.2

7.7

1735

15093

N06AX22

ATC

agomelatine; oral

1.4

7.7

275

1910

T78.4

ICD-10 Finland

Allergy, unspecified

1.3

7.7

543

4199

A11CC03

ATC

alfacalcidol; systemic

1.6

7.7

184

1176

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.4

7.7

343

2478

N05BA12

ATC

alprazolam; oral

1.2

7.7

921

7577

UJH02

NOMESCO Finland

Anoscopy

1.4

7.7

349

2529

34301

ICD-8 Finland

Cerebral spastic infantile paralysis, Diplegia spastica

14.9

7.7

CBJ40

NOMESCO Finland

Resection of levator muscle of eyelid

2.3

7.7

233

L14

ICPC

Leg/thigh symptom/complaint

1.2

7.7

820

6666

L50.9

ICD-10 Finland

Urticaria, unspecified

1.3

7.7

447

3367

R04.0

ICD-10 Finland

Epistaxis

1.3

7.7

591

4625

SJA01

NOMESCO Finland

Assesment of orthodontic treatment need

2.6

7.7

167

SCA02

NOMESCO Finland

Preventive oral health care

1.2

7.7

1479

12713

E23.01

ICD-10 Finland

Isolated deficiency of growth hormone

2.8

7.7

133

H06.2*E05.9

ICD-10 Finland

Dysthyroid exophthalmos

2.4

7.6

215

RS211, ,

NOMESCO Finland

2.3

7.6

246

NA1BG, ,

SPAT

1.5

7.6

211

1393

3650A

ICD-9 Finland

Glaucoma, Borderline glaucoma [glaucoma suspect][SUSPICIO GLAUCOMATIS (AVOKULMA)]

3.8

7.6

K03.64

ICD-10 Finland

Dental calculus supragingival

1.1

7.6

4560

42178

N89

ICPC

Migraine

1.3

7.6

522

4022

H43.1

ICD-10 Finland

Vitreous haemorrhage

1.5

7.6

190

1227

KAC00

NOMESCO Finland

Nephrectomy

2.8

7.6

128

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.4

7.6

327

2350

SPAT1053

SPAT

Memory test

1.2

7.6

774

6262

N03AX24

ATC

cannabidiol; oral

18.3

7.6

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.8

7.6

111

625

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.4

7.6

379

2791

H35.37

ICD-10 Finland

Macular holes

1.8

7.6

102

560

A07AA02

ATC

nystatin; oral

1.3

7.6

463

3513

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.4

7.6

269

1868

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

2.2

7.6

292

I73.0

ICD-10 Finland

Raynaud syndrome

1.6

7.5

178

1135

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

1.5

7.5

203

1333

L16

ICPC

Ankle symptom/complaint

1.2

7.5

1447

12431

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

7.5

330

2378

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

1.4

7.5

280

1961

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

1.6

7.5

172

1089

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.2

7.5

748

6034

CFW99

NOMESCO Finland

Other operation on conjunctiva

3.6

7.5

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

1.6

7.5

148

904

R96

ICPC

Asthma

1.2

7.5

1028

8572

N06AG02

ATC

moclobemide; oral

1.4

7.5

354

2583

SBB10

NOMESCO Finland

Dental impressions

1.2

7.5

976

8099

CM2S4

NOMESCO Finland

Follow-up photography of age-related macular degeneration lesions

2.4

7.5

211

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

1.6

7.5

150

920

G70.0

ICD-10 Finland

Myasthenia gravis

2.8

7.4

124

L04

ICPC

Chest symptom/complaint

1.3

7.4

667

5317

Q89.7

ICD-10 Finland

Multiple congenital malformations, not elsewhere classified

7.1

7.4

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.5

7.4

190

1234

T90.5

ICD-10 Finland

Sequelae of intracranial injury

1.8

7.4

101

556

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

1.5

7.4

205

1354

K06.19

ICD-10 Finland

Gingival hyperplasia UNS

2.3

7.4

218

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.2

7.4

1443

12412

CGD00

NOMESCO Finland

Keratotomy for error of refraction

79.8

7.4

S01GX05

ATC

lodoxamide; ophthalmic

1.7

7.4

118

681

S01BA01

ATC

dexamethasone; ophthalmic

1.4

7.4

286

2017

M01AC06

ATC

meloxicam; systemic, rectal

1.1

7.4

3750

34371

T86

ICPC

Hypothyroidism/myxoedema

1.3

7.4

448

3395

I95.1

ICD-10 Finland

Orthostatic hypotension

1.5

7.4

228

1541

Z71.9

ICD-10 Finland

Counselling, unspecified

1.2

7.4

873

7174

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.2

7.4

918

7583

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.5

7.4

240

1639

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

1.7

7.4

123

719

D02AX

ATC

Other emollients and protectives

1.4

7.4

348

2540

Q87.8

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

13.3

7.4

H18.8

ICD-10 Finland

Other specified disorders of cornea

2.1

7.3

322

L29

ICPC

Musculoskeletal sympt/complt other

1.2

7.3

918

7588

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

1.7

7.3

137

826

TJD20

NOMESCO Finland

Change of gastrostomy tube

2.5

7.3

171

R62.8

ICD-10 Finland

Other lack of expected normal physiological development

2.4

7.3

189

CKD20

NOMESCO Finland

Removal of vitreous body substitute

2.5

7.3

183

HA1RA, ,

SPAT

1.3

7.3

461

3514

M02AA10

ATC

ketoprofen; topical

1.2

7.3

1469

12668

GD1AA, ,

SPAT

1.1

7.3

2050

18123

3508

FHL

Transposition or anteposition

+∞

7.3

37309

ICD-8 Finland

Strabismus, Unspecified

+∞

7.3

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

1.7

7.3

117

677

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.2

7.3

1430

12309

U02

ICPC

Urinary frequency/urgency

1.2

7.3

1598

13876

F93

ICPC

Glaucoma

2.6

7.3

154

G04BD09

ATC

trospium; oral

1.6

7.3

164

1036

D06BB03

ATC

aciclovir; topical

1.3

7.3

430

3249

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

1.8

7.2

106

597

M03BC51

ATC

orphenadrine, combinations; systemic

1.1

7.2

2988

27065

D10AF01

ATC

clindamycin; topical

1.3

7.2

483

3710

F81.8

ICD-10 Finland

Other developmental disorders of scholastic skills

2.4

7.2

184

R5599

NOMESCO Finland

Other rehabilitation service

1.4

7.2

255

1770

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

2.1

7.2

311

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.4

7.2

300

2144

Q90

ICD-10 Finland

Down syndrome

15.7

7.2

S01

ICPC

Pain/tenderness of skin

1.3

7.2

453

3453

F80.1

ICD-10 Finland

Expressive language disorder

1.8

7.2

104

584

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.3

7.2

649

5180

P05.1

ICD-10 Finland

Small for gestational age

3.3

7.2

TCF00

NOMESCO Finland

Subconjunctival therapeutic injection

3.3

7.2

N05AH03

ATC

olanzapine; systemic

1.3

7.2

671

5377

Z01.2

ICD-10 Finland

Dental examination

1.1

7.2

6561

61919

3745

FHL

Hard membrane girding, cerclage with coagulation

4.3

7.2

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.3

7.2

413

3109

X84

ICD-10 Finland

Intentional self-harm by unspecified means

2.4

7.1

185

CJF20

NOMESCO Finland

Removal of artificial lens

7.3

7.1

D02

ICPC

Abdominal pain epigastric

1.3

7.1

680

5460

D10AX03

ATC

azelaic acid; topical

1.2

7.1

927

7691

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.3

7.1

437

3318

R51

NOMESCO Finland

Aids services

4.5

7.1

E70.3

ICD-10 Finland

Albinism

19.9

7.1

H50.39

ICD-10 Finland

Intermittent heterotropia

19.9

7.1

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

1.7

7.1

115

667

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

2.1

7.1

280

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

1.9

7.1

429

R01AD11

ATC

triamcinolone; nasal

1.2

7.1

849

6987

Q93.5

ICD-10 Finland

Other deletions of part of a chromosome

7.9

7.1

G04CB01

ATC

finasteride; oral

1.3

7.1

557

4374

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.3

7.1

583

4604

F98.2

ICD-10 Finland

Feeding disorder of infancy and childhood

2.9

7.0

106

RD210, ,

NOMESCO Finland

1.5

7.0

201

1338

SDA03

NOMESCO Finland

Periodontal treatment

1.1

7.0

5324

49781

P27.1

ICD-10 Finland

Bronchopulmonary dysplasia originating in the perinatal period

5.6

7.0

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

7.0

362

2680

H66.4

ICD-10 Finland

Suppurative otitis media, unspecified

1.9

7.0

473

H60.8

ICD-10 Finland

Other otitis externa

1.4

7.0

323

2350

A05

ICPC

Feeling ill

1.2

7.0

879

7271

S01EX03, ,

ATC

1.8

7.0

481

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.2

7.0

1330

11420

S01GX09

ATC

olopatadine; ophthalmic

1.4

7.0

295

2115

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.0

7.0

322

M01AB05

ATC

diclofenac; systemic, rectal

1.1

7.0

8082

77065

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

7.0

10352

99856

I49.1

ICD-10 Finland

Atrial premature depolarization

1.4

7.0

308

2225

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.3

7.0

417

3157

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.3

6.9

475

3662

EMB30

NOMESCO Finland

Adenotomy

1.3

6.9

437

3331

G81.1

ICD-10 Finland

Spastic hemiplegia

3.8

6.9

N07AA02

ATC

pyridostigmine; systemic

2.5

6.9

170

CJF45

NOMESCO Finland

Removal and implantation of artificial lens in anterior chamber with iridectomy or iridotomy

4.3

6.9

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.4

6.9

242

1678

J01DA01

ATC

[U] cefalexin

1.1

6.9

7567

71956

SPAT1139

SPAT

Nutrition survey

1.4

6.9

276

1960

E03.80

ICD-10 Finland

Hypothyroidism caused by autoimmune thyroiditis

1.5

6.9

235

1621

J46

ICD-10 Finland

Status asthmaticus

1.4

6.9

263

1853

H10

ICD-10 Finland

Conjunctivitis

1.2

6.9

922

7674

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

1.9

6.9

455

B02AA02

ATC

tranexamic acid; systemic

1.2

6.9

1650

14422

Q90.0

ICD-10 Finland

Trisomy 21, meiotic nondisjunction

5.8

6.9

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

1.9

6.9

441

F80.9

ICD-10 Finland

Developmental disorder of speech and language, unspecified

2.2

6.9

245

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.2

6.9

1372

11826

UJF30

NOMESCO Finland

Ileoscopy through colon

1.2

6.9

1033

8692

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

1.8

6.8

104

593

R07.3

ICD-10 Finland

Other chest pain

1.2

6.8

992

8318

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.5

6.8

188

1242

H61.8

ICD-10 Finland

Other specified disorders of external ear

1.8

6.8

513

H10.4

ICD-10 Finland

Chronic conjunctivitis

1.8

6.8

542

-31

ICPC

Medical examin/health eval partial

1.3

6.8

625

4998

TQW40, ,

SPAT

1.2

6.8

986

8266

HAHOM, ,

NOMESCO Finland

1.7

6.8

120

713

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

1.3

6.8

456

3507

CGD40

NOMESCO Finland

Implantation of intracorneal ring segments

8.2

6.8

Z99.1

ICD-10 Finland

Dependence on respirator

8.2

6.8

J01DA09

ATC

[U] cefadroxil

1.1

6.8

2952

26812

ND1CG

NOMESCO Finland

Wrist and hand extensive MRI examination with high intensity magnet

1.8

6.8

493

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.4

6.8

325

2380

F60.9

ICD-10 Finland

Personality disorder, unspecified

1.6

6.8

140

867

Y94.0

ICD-10 Finland

Accident at home

1.6

6.8

148

929

F79.1

ICD-10 Finland

Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment

4.1

6.8

E23.00

ICD-10 Finland

Panhypopituitarism

2.5

6.8

160

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

1.4

6.7

244

1702

R44

ICPC

Respiratory, Preventive immunization/medic

1.8

6.7

537

CDW99

NOMESCO Finland

Other operation on eyeball

39.8

6.7

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.4

6.7

304

2204

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

2.1

6.7

273

K07.58

ICD-10 Finland

Other abnormal function of teeth and jaws

1.8

6.7

523

Q85.9

ICD-10 Finland

Phakomatosis, unspecified

16.6

6.7

C07AB12

ATC

nebivolol; oral

1.4

6.7

237

1646

Q90.9

ICD-10 Finland

Down syndrome, unspecified

5.6

6.7

A01AB09

ATC

miconazole; local oral

1.2

6.7

767

6284

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.3

6.7

418

3183

L04AB06

ATC

golimumab; parenteral

1.8

6.7

102

582

R07.0

ICD-10 Finland

Pain in throat

1.2

6.7

935

7813

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.3

6.7

497

3875

K07.24

ICD-10 Finland

Open bite

1.6

6.7

156

995

N06AX03

ATC

mianserin; oral

1.3

6.6

381

2867

JDB10

NOMESCO Finland

Percutaneous gastrostomy

1.8

6.6

475

KFH00

NOMESCO Finland

Operation for undescended or ectopic testis

2.9

6.6

S05.0

ICD-10 Finland

Injury of conjunctiva and corneal abrasion without mention of foreign body

1.5

6.6

214

1462

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.4

6.6

344

2552

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.2

6.6

900

7505

137

Kela drug reimbursment

Uraemia requiring dialysis

1.9

6.6

384

G40

ICD-10 Finland

Epilepsy

1.8

6.6

476

H17.9

ICD-10 Finland

Corneal scar and opacity, unspecified

3.0

6.6

L60.0

ICD-10 Finland

Ingrowing nail

1.3

6.6

494

3857

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

1.6

6.6

158

1014

M01AX17

ATC

nimesulide; oral

1.1

6.6

2035

18101

S04

ICPC

Lump/swelling localized

1.2

6.6

1254

10769

L04AA05

ATC

[U] tacrolimus

4.0

6.6

104

Kela drug reimbursment

Thyroid insufficiency

1.3

6.6

592

4726

K03.29

ICD-10 Finland

Erosion of teeth occupational

1.5

6.6

163

1054

K80

ICPC

Cardiac arrhythmia NOS

1.2

6.6

770

6326

K03.66

ICD-10 Finland

Tooth plaque

1.2

6.6

880

7326

N30.2

ICD-10 Finland

Other chronic cystitis

1.9

6.5

413

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.3

6.5

390

2953

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

1.5

6.5

219

1508

B99

ICPC

Blood/lymph/spleen disease other

2.5

6.5

157

G80.8

ICD-10 Finland

Other cerebral palsy

10.0

6.5

N03AF03

ATC

rufinamide; oral

10.0

6.5

F81.0

ICD-10 Finland

Specific reading disorder

2.0

6.5

324

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.4

6.5

308

2252

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.5

6.5

204

1386

R49.01

ICD-10 Finland

Functional dysphonia

1.4

6.5

263

1873

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

1.4

6.5

318

2337

TCC10

NOMESCO Finland

Probing of lacrimal canaliculus/duct

2.1

6.5

264

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

1.5

6.5

167

1089

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.3

6.5

391

2965

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.1

6.5

2748

24918

R63.8

ICD-10 Finland

Other symptoms and signs concerning food and fluid intake

2.6

6.5

134

K06.18

ICD-10 Finland

Another gingival hyperplasia

2.3

6.5

188

G03FA14

ATC

dydrogesterone and estrogen; systemic

1.3

6.5

595

4763

WZC00, ,

SPAT

1.1

6.4

1792

15825

SPAT1254

SPAT

Administration of medicine

1.2

6.4

1517

13241

RT272, ,

NOMESCO Finland

2.5

6.4

146

C10AA07

ATC

rosuvastatin; oral

1.1

6.4

3301

30243

M13.9

ICD-10 Finland

Arthritis, unspecified

1.2

6.4

723

5914

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

1.4

6.4

273

1961

H18.2

ICD-10 Finland

Other corneal oedema

3.6

6.4

TCG00

NOMESCO Finland

Protection of cornea and sclera with soft lens

2.8

6.4

112

F59

ICD-10 Finland

Unspecified behavioural syndromes associated with physiological disturbances and physical factors

3.0

6.4

F39

ICD-10 Finland

Unspecified mood [affective] disorder

1.4

6.4

220

1522

R60.0

ICD-10 Finland

Localized oedema

1.2

6.4

1091

9284

78112

ICD-8 Finland

Other symptoms referable to nervous system and special senses, Nystagmus

14.2

6.4

L88

ICPC

Rheumatoid/seropositive arthritis

1.3

6.4

375

2834

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.2

6.4

1568

13730

-45

ICPC

Observ/health educat/advice/diet

1.4

6.4

273

1964

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.3

6.4

498

3910

RT171, ,

NOMESCO Finland

3.2

6.4

G93.0

ICD-10 Finland

Cerebral cysts

2.3

6.3

202

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

2.0

6.3

327

R01AD05

ATC

budesonide; nasal

1.2

6.3

704

5752

D07AB08

ATC

desonide; topical

1.2

6.3

1123

9586

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.2

6.3

828

6877

A01AB04

ATC

amphotericin B; local oral

1.4

6.3

319

2356

G03FB08

ATC

dydrogesterone and estrogen; systemic

1.3

6.3

567

4525

S01CA03

ATC

hydrocortisone and antiinfectives; ophthalmic

1.8

6.3

461

N03AA02

ATC

phenobarbital; systemic

4.0

6.3

D10BA01

ATC

isotretinoin; oral

1.2

6.3

847

7054

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.3

6.3

427

3291

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

1.7

6.3

108

638

E23.03

ICD-10 Finland

Lack of ACTH

2.8

6.3

102

S01ED02

ATC

betaxolol; ophthalmic

2.2

6.3

222

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.3

6.3

542

4306

H05.2

ICD-10 Finland

Exophthalmic conditions

3.0

6.3

108

Kela drug reimbursment

Myasthenia gravis

3.0

6.3

F31.8

ICD-10 Finland

Other bipolar affective disorders

1.5

6.3

209

1437

E34.39

ICD-10 Finland

Short stature, not elsewhere classified

2.4

6.3

172

G71.3

ICD-10 Finland

Mitochondrial myopathy, not elsewhere classified

5.1

6.3

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.2

6.3

678

5524

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.3

6.3

548

4360

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

1.9

6.3

398

R49.03

ICD-10 Finland

Atrophic dysphonia

1.9

6.3

391

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.1

6.3

6033

56951

FN1AD

NOMESCO Finland

CT of coronary arteries

1.5

6.3

164

1074

G54.0

ICD-10 Finland

Brachial plexus disorders

1.4

6.3

277

2004

D07XC01

ATC

betamethasone; topical

1.2

6.2

1080

9200

N04BC05

ATC

pramipexole; oral

1.2

6.2

592

4755

3501

FHL

Myotomy or tenotomy

+∞

6.2

LINSS, ,

NOMESCO Finland

+∞

6.2

37304

ICD-8 Finland

Strabismus, paralyticus. Paresis nervorum III, IV, VI

+∞

6.2

H50.5

ICD-10 Finland

Heterophoria

+∞

6.2

37008

ICD-8 Finland

Refractive errors, Alia definita

+∞

6.2

3788X

ICD-9 Finland

Strabismus and other disorders of binocular eye movements, Other disorders of binocular eye movements

+∞

6.2

Z010, H521,

ICD-10 Finland

+∞

6.2

H35.7

ICD-10 Finland

Separation of retinal layers

1.8

6.2

463

H00.00

ICD-10 Finland

Hordeolum

1.3

6.2

511

4036

DHB50

NOMESCO Finland

Turbinoplasty

1.4

6.2

248

1763

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

1.4

6.2

218

1515

R49.08

ICD-10 Finland

Other specified dysphonia

1.5

6.2

191

1294

N48.4

ICD-10 Finland

Impotence of organic origin

1.5

6.2

178

1189

H17.0

ICD-10 Finland

Adherent leukoma

7.0

6.2

H26.00

ICD-10 Finland

Infantile, juvenile and presenile cataract

7.0

6.2

T00.9

ICD-10 Finland

Multiple superficial injuries, unspecified

1.9

6.2

358

XCH05

NOMESCO Finland

Eye pressure longterm registration

1.9

6.2

379

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.1

6.2

7342

69924

J01MA14

ATC

moxifloxacin; systemic

1.2

6.2

773

6395

H25.9

ICD-10 Finland

Senile cataract, unspecified

1.7

6.1

538

ZXC20

NOMESCO Finland

Use of chemical agents

1.7

6.1

110

658

A06AC51

ATC

ispaghula, combinations; oral

1.3

6.1

403

3094

AXX01

NOMESCO Finland

Memory assessment

2.2

6.1

218

Z94.2

ICD-10 Finland

Lung transplant status

3.0

6.1

H35.0

ICD-10 Finland

Background retinopathy and retinal vascular changes

2.3

6.1

199

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

1.6

6.1

119

727

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

3.9

6.1

Z00.0

ICD-10 Finland

General medical examination

1.1

6.1

2137

19153

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.3

6.1

511

4046

R2110

NOMESCO Finland

Giving the first information

1.2

6.1

678

5541

RT172, ,

NOMESCO Finland

3.5

6.1

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

1.6

6.1

146

938

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.5

6.1

201

1381

A12AA04

ATC

calcium carbonate; oral

1.7

6.1

112

675

7410D

ICD-9 Finland

Spina bifida, With hydrocephalus[SPINA BIFIDA APERTA CUM HYDROCEPHALO REG LUMBALIS]

12.5

6.1

J45.8

ICD-10 Finland

Mixed asthma

1.4

6.1

276

2007

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.2

6.1

894

7512

CK2A4

NOMESCO Finland

Autofluorescence imaging of ocular fundus

2.3

6.1

175

H19.3*M35.0

ICD-10 Finland

Keratoconjunctivitis sicca

2.4

6.0

169

J30.3

ICD-10 Finland

Other allergic rhinitis

1.3

6.0

410

3162

Z00.8

ICD-10 Finland

Other general examinations

1.2

6.0

861

7212

H40.3

ICD-10 Finland

Glaucoma secondary to eye trauma

3.7

6.0

I89.9

ICD-10 Finland

Noninfective disorder of lymphatic vessels and lymph nodes, unspecified

3.7

6.0

3718X

ICD-9 Finland

Corneal opacity and other disorders of cornea, Other corneal disorders

8.5

6.0

H16.8

ICD-10 Finland

Other keratitis

2.5

6.0

145

Z61.8

ICD-10 Finland

Other negative life events in childhood

2.5

6.0

145

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

2.0

6.0

306

D01AC03

ATC

econazole; topical

1.3

6.0

457

3576

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

1.6

6.0

117

715

NFK30

NOMESCO Finland

Angulation, rotation or displacement osteotomy of femur

3.0

6.0

199

Kela drug reimbursment

Rufinamide

10.0

6.0

F38

ICPC

Eye, Other laboratory test NEC

1.6

6.0

129

808

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7273

60531

1.38

78.14

2.9

2.5

76.00

1529.96

nmol/l

0.50

6773

56359

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11615

106138

1.38

58.76

5.1

4.4

14.52

14.55

pmol/l

0.63

10817

98982

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

10726

96912

1.35

57.50

4.9

4.2

10.06

10.47

mm/h

2.86

10131

91709

(3018418) pH of Serum or Plasma

4482

35815

1.35

56.79

4.6

4.2

7.40

0.10

3181

25173

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7102

60640

1.31

56.48

8.8

7.2

1.22

1.21

mmol/l

0.99

6115

53005

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13108

122643

1.47

55.50

6.1

5.3

1.81

1.83

mu/l

1.09

12413

115917

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10705

97046

1.33

53.71

8.4

8.0

77.03

78.18

u/l

1.75

10228

92627

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4471

35986

1.34

53.16

2.4

2.2

207.34

199.45

u/l

0.16

4236

34225

(3006315) Basophils [#/volume] in Blood

7961

69363

1.30

53.05

7.7

6.6

0.04

e9/l

1.37

7024

60188

(3013115) Eosinophils [#/volume] in Blood

8190

71663

1.30

52.67

7.9

6.8

0.19

e9/l

0.21

7303

63227

(3001604) Monocytes [#/volume] in Blood

7945

69247

1.30

52.61

7.7

6.6

0.55

0.56

e9/l

3.62

7019

60132

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6384

54077

1.30

52.35

8.5

6.8

1.22

1.21

mmol/l

1.46

5941

50546

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1919

13507

1.47

50.11

2.4

2.3

364.57

377.99

nmol/l

2.32

1787

12618

(3019198) Lymphocytes [#/volume] in Blood

8108

71103

1.29

50.07

7.7

6.6

1.93

1.97

e9/l

2.03

7268

63226

(3013650) Neutrophils [#/volume] in Blood by Automated count

8693

77057

1.29

48.70

10.6

9.8

3.90

4.01

e9/l

4.68

7685

67049

(3037467) Urinalysis macro (dipstick) panel - Urine

9958

89921

1.30

47.91

5.2

4.3

1.52

6.46

—

124

(3024561) Albumin [Mass/volume] in Serum or Plasma

6372

54413

1.29

47.44

5.6

5.2

36.72

36.45

g/l

3.82

5943

51364

(3023103) Potassium [Moles/volume] in Serum or Plasma

13663

129624

1.49

46.53

18.2

15.4

3.94

mmol/l

0.07

13411

126849

(3035350) Ketones [Presence] in Urine by Test strip

8108

71623

1.27

44.90

4.3

3.6

4.57

4.07

estimate

0.10

1734

14702

(3019550) Sodium [Moles/volume] in Serum or Plasma

13629

129370

1.48

44.89

18.0

15.3

139.68

139.66

mmol/l

0.43

13410

126872

(3009261) Glucose [Presence] in Urine by Test strip

8145

72029

1.27

44.52

4.3

3.7

0.03

0.25

estimate

1.11

1667

14081

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7987

70485

1.27

44.32

3.6

3.2

98.24

101.11

ug/l

0.47

7546

66897

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6152

52598

1.28

44.31

2.1

2.0

98.55

97.31

pmol/l

1.29

3332

28449

(3015736) pH of Urine

6641

57400

1.27

43.44

3.7

3.2

6.22

0.14

3640

32355

(3021601) Nitrite [Presence] in Urine by Test strip

8011

70874

1.27

42.87

4.3

3.6

0.00

estimate

0.20

1720

14552

(3020564) Creatinine [Moles/volume] in Serum or Plasma

14344

137917

1.64

41.92

19.5

16.9

73.34

72.83

umol/l

1.16

14232

136503

(3006504) Eosinophils/Leukocytes in Blood

7259

63616

1.26

41.51

7.8

6.8

2.89

2.85

0.80

6891

60096

(3022096) Basophils/Leukocytes in Blood

7248

63564

1.26

40.99

7.9

6.9

0.69

0.01

6878

59978

(3019069) Monocytes/Leukocytes in Blood

7264

63752

1.26

40.69

7.9

6.9

8.65

8.59

1.00

6895

60276

(3044889) 12 lead EKG panel

9527

86315

1.27

40.51

4.0

3.5

0.43

3112.24

0.73

139

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4440

36749

1.29

40.41

1.4

1.94

1.79

u/ml

0.26

1241

10240

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

12528

117694

1.34

39.61

5.9

5.5

38.02

38.19

mmol/mol

1.28

11890

111967

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

193

681

2.85

39.51

1.1

2.79

8.49

nmol/l

1.11

129

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4063

33348

1.29

39.23

2.4

2.63

2.68

mg/l

0.71

3497

29114

(3002030) Lymphocytes/Leukocytes in Blood

7456

65847

1.25

38.74

7.8

6.7

29.49

29.22

1.36

7147

62878

(42870588) Differential panel, method unspecified - Blood

5313

45320

1.26

36.83

7.7

6.8

—

4.34

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

4980

42170

1.26

36.73

3.5

3.4

2.35

2.36

mmol/l

0.67

4582

38871

(40760892) CBC W Ordered Manual Differential panel - Blood

3958

32625

1.28

36.40

5.3

4.5

—

(3018010) Neutrophils/Leukocytes in Blood

7312

64733

1.24

36.05

7.6

6.6

55.95

56.20

1.18

7066

62226

(3013826) Glucose [Moles/volume] in Serum or Plasma

8252

74027

1.24

36.00

6.2

5.0

6.45

6.51

mmol/l

2.09

7784

69310

(3021960) Folate [Moles/volume] in Serum or Plasma

3967

32953

1.27

33.74

1.7

1.6

20.32

20.02

nmol/l

0.72

3438

28685

(3041096) Erythrocytes [Presence] in Urine by Automated

4715

39983

1.25

33.57

3.7

3.0

0.19

0.13

estimate

0.14

1440

11796

(3031040) Bacteria [#/volume] in Urine by Automated count

9354

85448

1.23

32.88

5.3

4.3

2088.02

1628.30

e6/l

0.30

161

1037

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

14251

137598

1.51

31.66

12.6

11.1

26.21

26.59

u/l

1.06

13925

134470

(3037522) Nuclear Ab [Titer] in Serum

2611

20717

1.31

31.48

1.5

1.4

509.64

520.59

titre

0.10

521

4244

(3007164) IgA [Mass/volume] in Serum or Plasma

3839

31991

1.26

31.33

1.6

1.5

2.14

2.24

g/l

3.86

2472

20485

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7345

65637

1.22

31.15

6.5

11.20

11.21

umol/l

0.01

6992

62447

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2106

16255

1.34

30.82

8.2

6.5

1.07

mmol/l

0.55

1940

15248

(3005719) IgG [Mass/volume] in Serum or Plasma

1496

10982

1.40

30.06

3.2

2.8

10.19

10.49

g/l

1.96

1371

10220

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

6141

54049

1.22

29.80

4.1

3.5

0.11

0.28

estimate

0.83

1473

12029

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2975

24211

1.28

29.23

1.8

1.7

29004068.45

33213757.10

pmol/l

0.14

2479

20832

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2300

18102

1.31

29.20

2.6

2.5

29.35

29.54

0.71

2243

17622

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6133

54058

1.22

29.08

2.0

1.9

1.32

1.37

mmol/l

4.50

5213

46735

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4716

40538

1.23

28.45

2.9

2.7

56.64

63.99

u/l

2.06

4362

37843

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1252

9010

1.42

28.15

4.8

4.2

79.78

83.26

ng/l

0.58

1090

7992

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

12745

121230

1.29

28.15

4.8

4.5

5.73

5.78

mmol/l

4.27

11888

113839

(3013005) Retinol [Moles/volume] in Serum or Plasma

196

830

2.37

27.80

2.6

2.4

1.98

1.84

umol/l

1.21

178

773

(3010813) Leukocytes [#/volume] in Blood

14807

144570

1.79

27.80

24.8

21.1

6.58

6.69

e9/l

10.27

14565

141641

(3035941) MCH [Entitic mass]

14802

144526

1.77

27.51

24.7

21.0

30.15

0.04

14694

143402

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1469

10907

1.38

27.45

2.4

2.3

12.63

12.47

nmol/l

0.30

1333

9990

(3024731) MCV [Entitic mean volume] in Red Blood Cells

14801

144520

1.77

27.42

24.7

21.0

90.33

90.36

0.33

14692

143395

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

14802

144541

1.77

27.29

25.5

21.5

41.39

41.01

0.36

14689

143355

(3026361) Erythrocytes [#/volume] in Blood

14802

144547

1.77

27.20

24.7

21.0

4.53

e12/l

0.13

14559

141647

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1502

11215

1.37

27.08

3.6

3.1

—

(3007461) Platelets [#/volume] in Blood

14795

144471

1.76

27.03

24.8

21.1

257.85

258.60

e9/l

0.76

14583

141899

(3019309) Folate [Moles/volume] in Red Blood Cells

2185

17260

1.30

26.79

1.8

1.7

1201.47

1160.50

nmol/l

1.32

1644

13432

(3000963) Hemoglobin [Mass/volume] in Blood

14802

144588

1.76

26.59

25.0

21.2

135.76

135.87

g/l

0.46

14696

143489

(3015171) Extractable nuclear Ab [Units/volume] in Serum

846

5724

1.50

26.24

1.3

1.54

0.98

u/ml

0.38

442

(3000850) Epithelial cells [#/volume] in Urine

3306

27544

1.25

26.20

3.3

2.7

6.45

6.33

e6/l

0.18

3014

25003

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4985

43376

1.22

26.07

3.7

3.2

89.17

62.33

ng/l

0.23

2902

25631

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12060

114194

1.25

26.06

20.0

16.9

13.41

13.43

1.51

11937

112725

(3005322) IgE [Units/volume] in Serum or Plasma

1423

10638

1.37

25.39

1.4

1.3

194.52

236.37

u/ml

1.06

1321

9930

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2512

20351

1.27

25.14

4.8

3.9

0.82

mmol/l

0.42

2332

19323

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3552

29948

1.24

25.07

2.1

1.9

0.98

1.10

mg/l

1.54

2661

22800

(3029937) Albumin [Presence] in Urine by Test strip

4412

38071

1.22

24.81

4.5

3.8

0.00

estimate

5.54

1617

13694

(40768797) Stomach Pathology biopsy report

2182

17398

1.29

24.75

1.3

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

252

1241

2.04

24.63

1.2

1.1

32.53

40.72

mg/l

3.81

198

1054

(3007853) Bacteria identified in Skin by Aerobe culture

1979

15611

1.30

24.33

1.9

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

676

4438

1.54

24.16

9.6

5.9

1.38

1.36

mg/l

0.31

634

4165

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

246

1210

2.04

24.14

1.1

216.64

241.97

mg/l

1.73

210

1082

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1296

9629

1.37

23.99

3.5

4.54

4.58

pmol/l

0.63

1185

8728

(3026782) Osmolality of Urine

2831

23380

1.25

23.94

3.3

2.8

529.21

536.02

mosm/kgh2o

0.82

2497

20508

(1616796) Gas panel - Central venous blood

436

2582

1.70

23.77

4.8

3.7

—

(3048689) Calprotectin [Mass/mass] in Stool

2561

20927

1.26

23.71

2.5

2.6

108.52

121.87

ug/g

1.37

2063

16748

(3032080) INR in Blood by Coagulation assay

5861

52118

1.20

23.63

12.4

11.5

1.18

inr

0.18

4894

43203

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

13208

126761

1.29

23.38

5.1

4.6

4.68

4.70

mmol/l

2.53

12503

120889

(3021589) Normoblasts [#/volume] in Blood

6730

60622

1.19

23.36

12.8

10.7

0.00

e9/l

0.18

5544

49254

(3022948) Iron [Moles/volume] in Serum or Plasma

2598

21336

1.26

22.96

2.9

2.6

13.86

13.85

umol/l

0.02

2406

20071

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

565

3604

1.58

22.94

1.5

430.31

497.96

mg/l

4.86

536

3460

(3018095) Leukocytes [#/volume] in Urine

5461

48356

1.19

22.84

4.7

3.8

71.68

79.97

e6/l

0.40

3827

32829

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5228

46129

1.20

22.70

3.7

3.4

29.96

32.74

u/l

2.70

4974

43805

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

13301

127853

1.29

22.64

5.6

5.1

2.76

2.79

mmol/l

3.76

12584

121463

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

13638

131539

1.32

22.55

16.3

13.8

21.22

22.26

mg/l

3.24

11190

106308

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

817

5658

1.46

22.53

2.2

2.0

39.77

40.29

u/l

0.31

746

5155

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3481

29562

1.22

22.51

3.2

3.1

954.91

1069.73

ng/l

0.74

2868

24955

(4027681) Cerebrospinal fluid IgG ratio and IgG index

205

970

2.12

22.34

1.3

1.2

0.60

0.64

ratio

0.78

116

564

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

511

3209

1.61

22.16

1.5

1.4

3.57

3.66

mmol/l

1.48

476

3056

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

514

3236

1.60

22.06

1.7

1.6

9032.38

1201.61

e6/l

0.55

411

2502

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

12784

122365

1.26

22.06

14.5

12.9

87.88

87.87

ml/min/173m2

0.01

11719

111252

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1223

9129

1.36

21.92

4.8

3.8

1.23

mmol/l

0.34

1025

7957

(3028626) Oxygen [Partial pressure] in Capillary blood

615

4045

1.54

21.81

8.7

5.2

8.97

8.88

kpa

0.57

605

3942

(40767503) Oxygen content in Capillary blood by calculation

402

2388

1.69

21.70

3.1

2.6

16.92

16.81

0.32

396

2338

(3027315) Oxygen [Partial pressure] in Blood

407

2427

1.69

21.65

4.7

3.9

8.79

8.82

kpa

0.12

397

2383

(3010421) pH of Blood

566

3661

1.56

21.64

4.6

3.6

7.41

0.01

557

3621

(3012501) Base excess in Blood by calculation

404

2407

1.69

21.57

4.8

3.9

2.21

2.36

mmol/l

0.58

279

1581

(3013290) Carbon dioxide [Partial pressure] in Blood

404

2408

1.69

21.53

4.8

3.9

5.04

5.01

kpa

0.30

394

2365

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

505

3185

1.60

21.52

1.6

24.13

24.88

e6/l

0.04

378

2316

(3002582) Erythrocytes [#/volume] in Urine

4643

40682

1.20

21.47

4.0

3.3

61.68

68.42

e6/l

0.18

3596

30472

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2404

19723

1.25

21.26

3.0

2.5

2.41

2.40

g/l

0.63

2211

18375

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10159

95204

1.19

21.14

3.7

3.3

39.79

41.99

u/l

2.31

9639

90886

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

12506

119572

1.24

20.81

4.3

3.9

1.25

1.27

mmol/l

2.30

11756

112816

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13115

126114

1.26

20.38

5.0

4.5

1.48

1.47

mmol/l

1.83

12391

119756

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1312

10010

1.33

20.31

2.4

21.90

20.29

au/ml

0.26

122

1251

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1204

9075

1.35

20.22

13.4

9.6

24.81

24.75

mmol/l

0.22

1195

9031

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3163

26885

1.22

19.89

1.4

1.3

26.15

31.03

iu/ml

1.11

907

7962

(3022145) Colonoscopy Study observation

1842

14750

1.28

19.87

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

223

1141

1.96

19.67

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

172

800

2.15

19.65

1.1

1.10

u/l

0.02

331

(40761536) Microorganisms panel - Urine sediment

1389

10738

1.32

19.58

4.8

3.6

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1219

9289

1.33

19.00

1.3

55.76

49.67

au/ml

0.33

579

(3014051) Protein [Presence] in Urine by Test strip

4577

40385

1.18

18.97

3.1

2.8

0.10

0.05

0.55

648

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

273

1513

1.81

18.84

3.2

2.7

22.35

21.24

nmol/l

0.69

260

1450

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.75

18.69

8.7

7.9

—

(3027945) Reticulocytes/Erythrocytes in Blood

1617

12839

1.28

18.60

3.5

2.9

1.67

1.75

2.70

1448

11602

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2190

18030

1.24

18.55

3.0

2.6

23.48

23.31

0.22

2028

16882

(3030467) Casts [#/volume] in Urine by Automated count

4026

35216

1.19

18.32

3.8

3.2

0.32

0.36

e6/l

0.50

2976

25198

(36304419) Bacteria [Presence] in Urine

3893

33956

1.19

18.30

3.7

3.1

4.47

148.24

estimate

0.60

105

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2687

22640

1.22

18.24

2.8

2.9

2.43

2.44

mmol/l

2.02

2384

20352

(3033658) Prothrombin time (PT) actual/Normal

3764

32840

1.19

17.49

4.7

4.3

93.07

92.45

0.90

3663

32111

(3028026) IgM [Mass/volume] in Serum or Plasma

1130

8627

1.33

17.35

2.1

1.9

1.34

1.27

g/l

0.42

1040

8050

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1728

13958

1.26

17.21

1.9

1.8

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2299

19173

1.23

17.15

1.9

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1484

11776

1.28

17.09

1.3

1.2

133.83

143.62

u/ml

0.48

582

4490

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1650

13271

1.27

17.03

1.9

1.8

—

(3006245) CD3-CD19+ cells/cells in Blood

159

760

2.10

17.00

3.3

2.8

11.40

11.33

0.02

151

728

(3021901) Oxygen saturation in Capillary blood

375

2339

1.61

16.82

4.5

3.1

91.40

90.98

0.74

369

2280

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

643

4509

1.44

16.62

2.0

1.9

0.23

g/l

0.57

604

4321

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

4.53

16.42

7.2

5.2

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2623

22273

1.21

16.25

3.9

3.6

402.52

462.56

ng/l

0.26

1793

15230

(3009508) Creatinine [Moles/volume] in Urine

4700

41977

1.17

16.14

3.8

3.5

7.87

7.90

mmol/l

0.17

4091

36489

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

154

743

2.08

16.09

2.7

2.5

26.55

27.80

umol/l

0.87

143

710

(3020961) Endomysium IgA Ab [Titer] in Serum

1058

8105

1.32

15.85

1.1

1.2

210.00

203.69

titre

0.03

254

(3018133) Calcium [Moles/volume] in Urine

394

2.49

15.79

2.4

2.9

2.66

2.68

mmol/l

0.03

365

(3020630) Protein [Mass/volume] in Serum or Plasma

1146

8882

1.31

15.78

2.6

66.73

g/l

0.00

1065

8270

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

4.37

15.75

7.4

5.3

71050.00

521586.75

u/ml

0.46

(3000494) Fungus identified in Specimen by Culture

1953

16150

1.23

15.69

1.6

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

214

1169

1.83

15.57

3.0

2.3

13.10

13.32

0.12

207

1144

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1233

9668

1.29

15.55

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

780

5729

1.38

15.43

1.6

1.5

9.28

9.58

u/l

0.24

598

4542

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

210

1147

1.83

15.30

3.1

2.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

649

4636

1.41

15.16

2.0

1.8

1.18

1.19

g/l

0.46

616

4455

(3000060) B lymphocytes [#/volume] in Blood

133

624

2.13

14.99

3.2

2.7

0.27

0.30

e9/l

0.22

310

(1175426) CD3 cells/Lymphocytes in Blood

218

1213

1.80

14.96

3.0

2.4

73.27

72.80

0.17

211

1172

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

507

3469

1.47

14.94

1.3

45.88

43.61

u/ml

0.09

304

(3023420) DNA double strand Ab [Units/volume] in Serum

820

6105

1.36

14.89

2.0

1.9

7.28

6.96

iu/ml

0.11

173

1455

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1022

7862

1.32

14.85

3.0

130.00

157.62

ng/l

2.13

936

7108

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

655

4707

1.40

14.78

1.8

40.91

41.30

nmol/l

0.13

643

4620

(3023520) Reticulocytes [#/volume] in Blood

1222

9641

1.29

14.68

3.3

2.8

69.27

70.34

e9/l

0.44

893

6851

(3045462) Protein/Creatinine [Ratio] in Urine

320

2.59

14.62

6.8

6.1

55.22

210.20

mg/mmol

0.52

294

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1030

7968

1.31

14.37

1.2

1.1

27.24

6.09

u/ml

0.35

(3026493) Urate [Moles/volume] in Serum or Plasma

3685

32528

1.17

14.35

2.8

2.6

328.62

329.42

umol/l

0.19

3291

29399

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2863

24792

1.18

14.05

1.4

1.3

7.75

10.24

u/ml

1.49

1145

10220

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1100

8629

1.29

13.81

1.7

—

(40758558) Short blood count panel - Blood

4457

40039

1.15

13.60

6.6

6.4

—

(3011412) CD3 cells [#/volume] in Blood

246

1457

1.69

13.60

3.2

2.7

1364.70

1282.12

e6/l

0.64

205

1219

(3015235) Bicarbonate [Moles/volume] in Capillary blood

565

4017

1.42

13.58

5.0

3.1

24.26

24.60

mmol/l

1.37

556

3951

(3023368) Bacteria identified in Blood by Culture

3550

31380

1.17

13.43

4.5

4.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

142

713

1.99

13.39

3.2

2.5

25.85

28.18

1.57

135

688

(3009466) Valproate [Moles/volume] in Serum or Plasma

300

1878

1.60

13.35

6.1

5.8

407.18

371.45

umol/l

3.27

267

1662

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

862

6580

1.32

13.24

12.6

10.5

16.12

16.10

0.07

840

6348

(3042936) Bacteria identified in Isolate by Culture

2089

17677

1.21

13.18

2.1

2.0

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

556

3982

1.41

12.84

2.4

409.78

478.25

ug/l

0.28

513

3724

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

478

3336

1.44

12.75

1.9

199.11

195.25

pmol/l

0.32

461

3193

(3002179) Metamyelocytes/Leukocytes in Blood

1354

10995

1.25

12.74

4.8

4.4

0.54

0.68

1.99

390

3181

(1002224) Polysomnography panel

954

7427

1.30

12.69

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

950

7398

1.30

12.61

7.1

4.5

1.50

1.47

mmol/l

0.10

692

5394

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1314

10651

1.25

12.56

10.9

9.1

122.59

122.04

g/l

0.44

1293

10403

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

250

1523

1.65

12.45

1.1

—

10.49

—

(3019150) Specific gravity of Urine by Refractometry

3593

31969

1.16

12.27

4.1

3.6

1.02

1.21

kg/l

1.35

2312

20682

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

380

2.31

12.22

1.4

1.3

125.62

114.09

nmol/l

0.35

285

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

611

4491

1.37

12.09

1.4

1.3

48.05

39.83

u/ml

0.25

250

(3017181) Myelocytes/Leukocytes in Blood

1400

11476

1.24

12.08

5.1

4.6

0.78

0.90

0.99

403

3303

(3007930) Methemoglobin/Hemoglobin.total in Blood

599

4402

1.37

11.87

6.1

5.1

0.89

0.04

572

4151

(3012516) Albumin [Mass/volume] in Urine

3976

35710

1.15

11.83

3.6

3.5

45.11

53.16

mg/l

1.39

2460

22794

(3021440) Promyelocytes/Leukocytes in Blood

1341

11007

1.23

11.42

5.2

4.7

0.07

0.11

1.99

345

2844

(3009343) pH of Capillary blood

1045

8344

1.27

11.37

7.1

4.5

7.41

1.43

905

6857

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

195

1141

1.71

11.36

3.4

2.9

214.29

219.23

e6/l

0.11

153

915

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

655

4919

1.34

11.29

1.6

1.5

54.45

2.66

iu/ml

0.91

121

872

(3020779) Urea [Moles/volume] in Serum or Plasma

1297

10628

1.24

11.21

11.7

8.3

8.28

8.58

mmol/l

0.97

1259

10243

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

571

4207

1.37

11.15

2.1

2.0

3.47

6.77

iu/l

0.91

221

1831

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

645

4843

1.34

11.14

3.7

3.1

94.64

94.40

0.10

613

4691

(3025159) Blasts/Leukocytes in Blood

1360

11216

1.23

11.06

5.4

4.9

0.59

0.25

0.56

343

2738

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

189

1105

1.71

11.06

3.2

2.8

511.63

536.40

e6/l

0.32

143

851

(3010015) Selenium [Moles/volume] in Serum or Plasma

211

2.70

10.99

2.2

2.3

1.31

1.24

umol/l

0.45

169

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1484

12357

1.22

10.98

6.9

4.7

5.84

5.83

kpa

0.30

1453

12046

(3013139) Helicobacter pylori Ag [Presence] in Stool

1185

9643

1.24

10.92

1.3

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

403

2808

1.44

10.91

2.7

2.2

132.04

131.28

g/l

0.26

337

2202

(21494815) CD4 cells/Lymphocytes in Specimen

217

1323

1.64

10.84

3.0

2.5

42.53

39.23

2.57

212

1304

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1064

8564

1.26

10.81

7.0

4.5

5.11

kpa

0.05

1027

8224

(3000570) Elastase.pancreatic [Mass/mass] in Stool

518

3786

1.38

10.66

1.5

1.4

287.00

282.30

ug/g

0.19

279

2110

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

449

3204

1.41

10.65

1.7

—

(3036489) Thrombin time

713

5468

1.31

10.63

2.7

2.6

20.89

20.80

0.22

609

4784

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

564

4181

1.36

10.61

1.4

1.3

4.49

7.14

u/ml

0.61

375

(3011397) Hemoglobin [Presence] in Urine by Test strip

3601

32328

1.14

10.57

3.9

3.6

0.26

0.42

0.29

243

(3012544) pH of Venous blood

1495

12503

1.21

10.57

6.9

4.7

7.37

7.38

0.18

920

7187

(3023323) Follitropin [Units/volume] in Serum or Plasma

1256

10324

1.23

10.54

1.5

1.4

24.01

25.50

iu/l

0.87

1027

8773

(3002032) Base excess in Venous blood by calculation

1446

12060

1.21

10.51

7.0

4.7

1.64

1.69

mmol/l

0.21

1266

10516

(3035637) Corticotropin [Mass/volume] in Plasma

301

1996

1.51

10.48

1.7

1.6

29.28

30.48

ng/l

0.10

301

1991

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

149

828

1.80

10.43

2.4

2.8

1052.28

973.67

u/ml

0.13

149

819

(36660697) Celiac disease serology panel - Serum

1553

13058

1.21

10.37

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6650

62042

1.12

10.37

2.8

—

estimate

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

256

1645

1.56

10.30

1.7

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

637

4831

1.33

10.29

5.8

4.9

1.68

1.67

0.16

605

4561

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

331

2248

1.48

10.27

1.7

404.72

377.50

mu/l

0.46

271

1808

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

606

4565

1.34

10.26

3.8

3.2

3.40

3.51

g/l

1.03

583

4368

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

461

3328

1.39

10.24

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

130

697

1.86

10.22

49.0

42.2

6.98

7.26

ug/l

0.84

119

638

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

597

4491

1.34

10.21

3.0

3.1

174.21

180.91

1.20

566

4292

(3019977) pH of Arterial blood

1520

12780

1.21

10.15

10.3

8.3

7.42

1.47

807

6781

(3020682) Albumin/Creatinine [Ratio] in Urine

4002

36259

1.13

10.14

4.4

4.2

8.03

9.55

mg/mmol

1.05

2442

22806

(3016244) Insulin [Units/volume] in Serum or Plasma

213

1316

1.62

10.13

3.2

3.3

23.48

24.75

mu/l

0.21

203

1250

(3014111) Lactate [Moles/volume] in Serum or Plasma

1286

10641

1.22

10.12

11.2

8.6

1.31

mmol/l

0.06

1260

10462

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

560

4180

1.35

10.09

1.4

1.3

8.41

9.40

u/ml

0.14

586

(3010375) cycloSPORINE [Mass/volume] in Blood

122

644

1.89

10.07

32.2

29.3

123.58

119.84

ug/l

0.21

101

533

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3123

27859

1.15

9.98

5.2

4.8

2.37

2.54

ug/l

0.19

2852

25509

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2524

22180

1.16

9.94

4.4

4.0

21.70

21.75

0.06

1096

9706

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

264

2.42

9.93

9.8

7.0

4420.29

3313.29

iu/ml

—

(3025941) Bacteria identified in Stool by Culture

988

7966

1.25

9.90

1.3

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

607

4606

1.33

9.79

1.4

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

734

5716

1.29

9.79

1.7

3.68

4.25

mg/l

0.75

549

4159

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

217

1360

1.60

9.75

2.3

2.2

32.67

32.49

0.26

217

1350

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1513

12763

1.20

9.75

10.3

8.3

5.09

kpa

0.11

1464

12310

(3027801) Oxygen [Partial pressure] in Arterial blood

1512

12759

1.20

9.70

10.3

8.3

13.11

12.96

kpa

0.48

1464

12299

(3024354) Oxygen [Partial pressure] in Venous blood

1260

10452

1.22

9.67

6.6

4.2

4.75

4.69

kpa

0.39

1232

10183

(3000492) Spirometry study

1686

14404

1.19

9.41

1.5

—

19.73

—

(4062490) Immunoglobulin typing, IgG

241

1561

1.55

9.41

1.4

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

155

2.83

9.36

1.8

1.7

2.07

2.06

mg/l

0.00

102

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

155

2.83

9.36

1.8

1.7

2.25

3.34

mg/l

0.94

108

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

155

2.83

9.36

1.8

1.7

1.33

1.24

mg/l

0.05

100

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

155

2.83

9.36

1.8

1.7

3.69

4.36

mg/l

0.28

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

155

2.83

9.36

1.8

1.7

1.66

1.73

mg/l

0.05

116

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

155

2.83

9.36

1.8

1.7

2.42

2.19

mg/l

0.08

108

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

155

2.83

9.36

1.8

1.7

1.59

2.70

mg/l

1.01

118

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

155

2.83

9.36

1.8

1.7

1.93

2.48

mg/l

0.27

112

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

155

2.83

9.36

1.8

1.7

0.80

1.11

mg/l

0.55

112

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

485

3584

1.36

9.36

2.3

2.1

10.60

11.19

mg/l

1.00

448

3379

(3027135) IgG subclass 1 [Mass/volume] in Serum

244

1589

1.54

9.30

1.4

1.3

6.46

6.62

g/l

0.41

183

1154

(3003396) Base excess in Arterial blood by calculation

1497

12670

1.20

9.29

10.3

8.3

0.85

0.80

mmol/l

0.17

1252

10425

(3028192) IgG subclass 2 [Mass/volume] in Serum

244

1590

1.54

9.27

1.4

1.3

3.01

2.89

g/l

0.56

182

1157

(3024139) IgG subclass 3 [Mass/volume] in Serum

244

1590

1.54

9.27

1.4

1.3

0.39

g/l

0.08

186

1147

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

402

2894

1.39

9.13

1.5

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

206

1298

1.59

9.08

1.3

1.4

5.33

5.52

umol/l

0.29

186

1160

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

983

7999

1.24

9.08

7.2

5.1

24.01

24.13

mmol/l

0.69

973

7926

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

417

3027

1.38

9.01

8.3

6.2

1138.37

1295.75

iu/ml

0.07

407

(40768443) Skin Pathology biopsy report

726

5710

1.28

8.98

1.2

—

(3016502) Oxygen saturation in Arterial blood

1343

11294

1.20

8.94

10.9

8.8

95.71

95.82

0.20

1306

10893

(3009445) Proteinase 3 Ab [Units/volume] in Serum

689

5391

1.29

8.88

1.6

19.21

9.84

iu/ml

0.57

158

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

160

2.74

8.85

1.8

1.7

1.46

2.19

mg/l

0.52

113

(3000012) Reticulocyte production index

218

1401

1.56

8.84

2.3

2.1

0.99

0.91

0.86

151

912

(3014576) Chloride [Moles/volume] in Serum or Plasma

1818

15714

1.17

8.80

9.5

7.8

104.73

104.50

mmol/l

1.23

1818

15707

(3047181) Lactate [Moles/volume] in Blood

463

3433

1.35

8.77

6.7

5.4

1.25

1.28

mmol/l

0.34

421

3025

(3008152) Bicarbonate [Moles/volume] in Arterial blood

822

6584

1.26

8.75

7.2

6.7

24.60

24.45

mmol/l

0.54

796

6288

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1120

9282

1.22

8.68

2.6

2.4

6167.90

6240.88

u/l

0.02

367

3643

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

157

2.73

8.59

7.0

6.1

2.51

2.30

mg/l

0.29

134

(3000991) Gas panel - Venous blood

1310

11031

1.20

8.59

13.1

9.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

174

2.64

8.59

5.0

3.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

173

1063

1.63

8.49

1.2

1.1

0.87

1.15

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

241

1599

1.51

8.47

1.8

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

153

2.74

8.44

1.4

1.3

0.55

0.58

iu/ml

0.08

(3021387) Prolactin [Units/volume] in Serum or Plasma

902

7339

1.24

8.35

1.7

323.62

309.07

mu/l

0.42

807

6645

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

11996

116288

1.13

8.35

20.3

17.3

333.20

332.89

g/l

3.54

11945

115672

(3039000) Anion gap in Blood by calculation

321

2259

1.42

8.34

7.8

6.6

10.92

11.27

mmol/l

1.17

299

2023

(3018572) Chloride [Moles/volume] in Blood

321

2260

1.42

8.32

7.8

6.6

104.86

105.21

mmol/l

0.61

299

2025

(3023419) Bacteria identified in Sputum by Culture

210

1358

1.55

8.32

2.7

—

(3011985) Renin [Units/volume] in Plasma

286

1979

1.45

8.16

1.7

1.6

56.89

68.54

mu/l

0.68

253

1802

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

173

1079

1.60

8.02

1.4

1.2

1.98

1.96

mmol/l

0.08

161

1016

(3049233) Organic acids panel - Urine

3.99

8.00

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

737

5901

1.26

7.89

1.9

—

32.21

—

(3010838) Calcium [Moles/time] in 24 hour Urine

319

2270

1.41

7.82

2.0

1.9

5.56

5.16

mmol/24h

0.60

294

2054

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

265

1825

1.45

7.77

1.4

355.40

490.63

pmol/l

0.96

220

1581

(42529406) Shigella sp [Presence] in Stool by Culture

488

3721

1.32

7.69

1.2

—

(3023410) Appearance of Cerebral spinal fluid

232

1565

1.48

7.57

1.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

293

2.15

7.50

1.3

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

326

2347

1.39

7.48

1.5

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

301

2138

1.41

7.47

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

2263

20114

1.14

7.43

1.7

—

(3013336) Amino acids [Identifier] in Serum or Plasma

108

2.95

7.42

2.0

3.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2466

22049

1.14

7.39

3.3

2.9

1.00

1.21

e6/l

0.72

1311

11301

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1904

16746

1.15

7.28

3.1

3.0

0.71

0.73

ug/l

0.17

1126

9963

(44790049) Parainfluenza type 3 nucleic acid detection

253

1751

1.45

7.26

1.8

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

253

1751

1.45

7.26

1.8

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

253

1752

1.45

7.24

1.8

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

253

1752

1.45

7.24

1.8

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

483

3710

1.31

7.24

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1532

13265

1.17

7.23

4.8

4.6

236.83

240.24

u/l

0.36

1464

12662

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

480

3687

1.31

7.20

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

546

4275

1.28

7.08

1.1

10.02

6.34

eliau/ml

0.49

624

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

192

2.39

7.07

1.4

1.3

1.40

1.65

iu/ml

0.50

(4094501) Cardiovascular stress test using bicycle ergometer

440

3354

1.32

6.99

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

150

938

1.60

6.95

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

110

635

1.73

6.92

2.8

2.6

56.55

51.18

umol/l

0.92

102

571

(3026389) Candida sp identified in Specimen by Organism specific culture

303

2185

1.39

6.92

1.4

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

245

2.20

6.86

2.2

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

124

743

1.67

6.81

1.6

1.7

2.17

7.54

nmol/l

0.94

103

602

(3016038) Potassium [Moles/volume] in Urine

129

781

1.65

6.81

2.4

1.5

34.67

34.47

mmol/l

0.03

117

704

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1763

15496

1.15

6.79

3.3

3.0

6.94

7.70

umol/l

0.88

1502

13445

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

325

2382

1.37

6.74

7.0

3.5

1190.53

1626.04

u/ml

0.20

128

(3004451) EKG impression Narrative

552

1.77

6.73

1.3

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

706

5734

1.24

6.70

1.4

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

268

1904

1.41

6.70

1.3

84.43

55.81

u/ml

0.74

105

(3049717) Cytology report of Urine Cyto stain

440

3385

1.30

6.56

2.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

429

3298

1.30

6.44

1.5

0.35

0.40

nmol/l

0.78

335

2574

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

164

1067

1.54

6.43

2.8

2.9

100.82

97.84

0.56

151

1001

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

163

1060

1.54

6.41

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

150

959

1.56

6.36

2.0

1.6

20.55

22.62

umol/l

0.42

137

899

(3017732) Neutrophils [#/volume] in Blood

1929

17142

1.14

6.31

2.7

3.1

4.41

4.38

e9/l

0.04

1707

15160

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

297

2170

1.37

6.31

1.4

1.2

133.33

120.57

titre

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

164

1072

1.53

6.31

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

347

2599

1.34

6.27

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

329

1.97

6.24

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

329

1.97

6.24

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

329

1.97

6.24

1.1

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

197

1342

1.47

6.21

1.7

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

582

4671

1.25

6.18

1.5

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

199

1363

1.46

6.11

4.3

9.2

7.33

7.34

mmol/l

0.02

169

1145

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

445

3465

1.29

6.08

1.4

1.3

3.73

2.92

u/ml

0.14

221

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

124

767

1.62

6.07

2.6

2.8

44.79

41.63

1.20

402

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1467

12839

1.15

6.00

5.6

5.9

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

114

693

1.64

5.99

1.5

1.2

77.88

73.55

0.24

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

451

3528

1.28

5.96

1.4

1.3

23.82

16.40

u/ml

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

264

1913

1.38

5.93

1.3

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

406

1.84

5.92

2.2

1.8

0.15

0.20

nmol/l

1.10

305

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

430

3348

1.29

5.90

1.9

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

458

1.79

5.85

1.2

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

452

3546

1.28

5.84

2.9

2.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

495

1.75

5.83

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

217

2.16

5.79

1.1

0.61

1.01

umol/24h

0.68

104

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

461

3631

1.27

5.77

2.0

2.2

10.04

10.15

g/l

0.20

420

3292

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

492

3910

1.26

5.72

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

290

2146

1.35

5.72

1.4

1.2

220.42

315.89

titre

0.39

168

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

3.59

5.71

1.4

1.2

1.00

1.16

u/field

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

146

953

1.53

5.70

1.8

1.5

8.93

6.95

ug/l

0.38

134

868

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

276

2030

1.36

5.67

1.6

1.4

17.63

14.14

u/ml

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

536

4314

1.25

5.59

1.2

4.56

4.12

0.36

649

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

260

2.03

5.59

2.2

2.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

336

2552

1.32

5.57

1.3

1.6

0.59

0.75

g/l

3.64

251

2014

(3029634) Reagin Ab [Titer] in Serum by VDRL

323

2440

1.33

5.56

2.0

3.50

10.96

titre

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1569

13871

1.14

5.55

2.2

2.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

835

7036

1.19

5.51

5.9

3.9

129.74

130.86

g/l

0.78

810

6854

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

119

748

1.59

5.49

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1047

8998

1.17

5.47

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

173

1183

1.46

5.41

1.2

1.3

2.28

3.59

u/ml

0.74

109

689

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

153

2.35

5.40

2.1

2.5

203.13

164.31

ug/g

0.54

136

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

103

628

1.64

5.39

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

245

1787

1.37

5.33

1.5

1.4

—

(3008295) Osmolality of Serum or Plasma

197

1387

1.42

5.28

1.8

1.6

283.48

281.23

mosm/kgh2o

0.88

149

1063

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1442

12733

1.14

5.20

2.5

2.6

32.99

43.44

u/l

1.86

1225

10844

(46235355) HIV 1 and 2 tests - Meaningful Use set

3875

36115

1.09

5.15

2.2

2.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

170

1172

1.45

5.12

1.4

1.2

125.78

113.15

pmol/l

0.96

170

1172

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

133

874

1.52

5.08

1.6

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

113

717

1.57

5.05

4.0

2.4

253.70

153.16

umol/l

1.37

362

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

405

3196

1.27

5.05

1.9

1.5

133.95

141.81

au/ml

0.54

105

905

(3001186) Copper [Moles/volume] in Serum or Plasma

443

1.73

5.03

1.4

1.3

16.41

16.87

umol/l

0.32

384

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

307

2341

1.31

4.99

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

307

2341

1.31

4.99

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

263

1967

1.34

4.90

2.5

2.6

23.63

27.19

iu/ml

0.21

166

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1124

9799

1.15

4.88

3.0

2.3

0.27

0.37

e6/l

1.87

1070

9307

(3012565) Volume of 24 hour Urine

592

1.62

4.85

2.1

1923.22

2033.64

0.53

543

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

261

1954

1.34

4.84

1.4

1.3

0.17

0.22

nmol/l

0.49

105

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

586

1.62

4.80

1.2

112.62

107.80

0.51

533

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

786

6679

1.18

4.75

13.7

10.8

24.18

24.19

mmol/l

0.02

769

6572

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

444

3570

1.25

4.74

1.5

6.22

11.57

iu/ml

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2150

19551

1.11

4.73

1.9

1.8

1.40

1.41

0.22

1922

17479

(3052851) Hemolysis interference index of Serum or Plasma

425

3402

1.25

4.72

3.0

3.56

2.36

index

1.12

242

1788

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

178

1259

1.41

4.70

1.5

1.4

75.29

78.43

0.18

(3027273) Bicarbonate [Moles/volume] in Venous blood

576

4768

1.21

4.66

5.4

3.5

25.27

25.24

mmol/l

0.10

560

4598

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

331

2578

1.28

4.62

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

322

2500

1.29

4.61

1.3

2.81

3.18

u/ml

0.19

142

929

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1367

12126

1.13

4.61

2.7

2.6

0.22

g/l

1.09

1288

11387

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

103

2.52

4.57

1.0

1.1

1.48

1.85

umol/24h

1.31

103

(3013512) EKG study

4077

38251

1.08

4.55

3.5

3.2

0.63

0.75

—

(3003181) Sodium [Moles/volume] in Urine

263

1992

1.32

4.53

2.1

1.6

66.43

62.72

mmol/l

0.70

217

1585

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

558

1.61

4.48

1.1

1.2

92.64

93.35

0.06

259

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2231

20387

1.11

4.46

3.5

3.0

3.54

3.16

e6/l

0.67

1074

9583

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

567

1.60

4.44

1.1

91.90

93.03

0.16

256

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

490

4012

1.22

4.44

2.0

2.2

2.80

2.88

g/l

0.92

453

3704

(3011288) Drugs identified in Urine by Screen method Nominal

783

6693

1.17

4.43

2.8

2.7

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

107

694

1.54

4.40

1.2

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

162

1143

1.42

4.37

3.7

3.5

13.91

14.27

index

0.16

116

722

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

512

4218

1.22

4.37

2.0

2.2

4.23

4.24

g/l

0.16

475

3912

(3044640) Blood type and Crossmatch panel - Blood

4482

42264

1.08

4.37

2.5

2.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

140

962

1.45

4.36

1.3

184.69

184.03

pmol/l

0.01

140

962

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

427

3453

1.24

4.36

1.9

1.5

—

(3042631) Mycobacterium sp identified in Specimen

179

1287

1.39

4.34

2.5

2.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

511

4213

1.22

4.33

2.0

2.2

3.55

3.69

g/l

1.99

474

3908

(3002256) Pathology report gross observation

1868

16943

1.11

4.31

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

294

2278

1.29

4.31

1.1

116.21

117.05

0.19

256

2090

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

423

3424

1.24

4.29

1.8

1.5

33.25

22.38

u/ml

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

550

1.60

4.26

1.1

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

511

4226

1.21

4.21

2.0

2.2

7.19

7.33

g/l

1.13

474

3915

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1819

16506

1.11

4.16

2.4

2.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

2.49

4.16

2.3

6.0

100.92

101.45

g/l

0.07

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

142

988

1.44

4.16

14.8

15.7

833.94

2128.22

nmol/l

0.49

132

956

(3018333) Ribosomal P Ab [Presence] in Serum

172

1238

1.39

4.16

1.2

—

(40768446) Kidney Pathology biopsy report

577

1.57

4.16

2.2

1.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1128

9956

1.14

4.13

2.6

70.24

72.40

ml/min/173m2

1.07

528

4044

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

668

5676

1.18

4.09

2.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

146

1025

1.42

4.08

20.8

21.5

1465.77

2334.05

nmol/l

0.46

137

994

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

122

828

1.47

4.08

2.0

1.9

138.33

135.41

0.17

116

786

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

379

3051

1.24

4.06

1.7

1.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

144

1011

1.42

4.03

1.0

—

(3037121) Protein [Mass/volume] in Urine

514

4273

1.20

4.03

4.6

3.8

332.81

402.21

mg/l

0.75

262

2079

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

136

945

1.44

4.03

1.2

1.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

512

1.60

4.01

2.6

2.1

28.93

30.86

0.69

512

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

219

1648

1.33

4.00

1.4

1.3

0.17

0.21

nmol/l

1.23

175

1256

(3024928) Oxygen saturation in Venous blood

387

3131

1.24

3.97

6.4

4.4

64.35

63.22

0.51

374

3049

(3028707) Methadone [Presence] in Urine by Screen method

479

3961

1.21

3.97

3.1

2.7

—

(3008898) HLA-B27 [Presence]

718

6154

1.17

3.96

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

650

1.52

3.90

2.3

2.6

24.39

184.47

ug/l

0.97

615

(3003329) Lymphocytes/Leukocytes in Synovial fluid

145

1026

1.41

3.90

1.6

1.5

33.55

34.18

0.06

621

(3034891) Synovial lining cells/cells in Synovial fluid

548

1.57

3.88

1.4

1.5

6.38

3.81

0.37

118

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

263

2040

1.29

3.87

1.7

1.8

653.33

2191.58

titre

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

304

2407

1.26

3.79

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

236

1.86

3.72

1.1

1.0

0.14

0.29

u/ml

0.36

146

(3020874) Milk IgE Ab [Units/volume] in Serum

183

1358

1.35

3.71

1.1

1.2

4.17

2.41

u/ml

0.45

537

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

173

1273

1.36

3.70

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

101

675

1.49

3.68

1.5

11.92

12.21

u/l

0.18

660

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

588

4998

1.18

3.63

2.0

1.8

1.46

1.47

g/l

0.15

506

4340

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

550

1.54

3.61

1.4

1.2

108.01

108.73

0.07

496

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

173

1280

1.35

3.59

1.3

1.2

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

182

1357

1.34

3.59

1.5

1.6

52.25

54.23

0.25

106

862

(3042733) HLA Ab [Presence] in Serum

504

1.56

3.57

4.9

4.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

305

2435

1.25

3.57

1.5

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

365

1.67

3.57

4.0

3.7

5.04

4.88

kpa

0.55

365

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

533

4502

1.19

3.55

1.2

1.1

1.49

2.42

u/ml

2.71

297

2493

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

366

1.66

3.54

4.0

3.7

10.05

10.55

kpa

1.05

366

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

303

2423

1.25

3.51

1.1

3.22

3.51

eliau/ml

0.10

130

1207

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

371

3036

1.22

3.47

2.2

0.00

g/l

1.03

321

2681

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

114

791

1.44

3.46

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

440

3665

1.20

3.44

2.2

2.3

0.65

0.72

g/l

0.17

377

3203

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

589

1.51

3.43

1.3

1.2

0.31

0.30

g/l

0.60

478

(40759836) Histone Ab [Presence] in Serum by Immunoblot

178

1333

1.33

3.42

1.3

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

439

1.59

3.42

1.5

1.2

22.40

17.16

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

311

2502

1.24

3.42

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

138

993

1.39

3.42

3.8

4.0

—

(3016228) CD19 cells/cells in Blood

502

1.55

3.41

2.5

2.1

8.18

8.82

0.24

487

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

236

1.82

3.41

1.0

1.1

0.01

0.15

u/ml

0.69

151

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

434

3614

1.20

3.40

1.7

1.4

275.78

248.29

u/ml

0.82

264

2213

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

159

2.01

3.39

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

326

1.68

3.36

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

176

1321

1.33

3.34

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

470

3952

1.19

3.32

1.1

4.37

5.91

u/ml

1.49

264

2242

(3008401) Mugwort IgE Ab [Units/volume] in Serum

454

3806

1.19

3.32

1.1

0.82

1.17

u/ml

0.74

211

1843

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

176

1323

1.33

3.31

1.3

1.2

—

(3020891) Body temperature

592

5076

1.17

3.31

5.3

4.5

36.92

36.93

°c

0.14

585

5032

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.41

3.29

1.3

1.2

40.48

29.99

mg/24h

1.12

(4195642) Thrombophilia screening test

288

2311

1.25

3.26

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

178

1344

1.32

3.26

2.7

3.4

2.97

9.62

nmol/l

0.96

173

1294

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

197

1509

1.30

3.25

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

369

3042

1.21

3.23

1.1

6.28

6.42

u/ml

0.03

174

1440

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1363

1.32

3.23

1.3

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.66

3.19

4.3

4.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

408

1.59

3.19

2.5

3.0

28.60

28.11

umol/l

0.14

300

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

302

2443

1.24

3.19

1.3

3.02

4.12

u/ml

1.96

152

1154

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

339

1.65

3.18

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

3178

29898

1.07

3.17

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

384

3185

1.21

3.17

2.1

2.2

0.02

g/l

0.09

342

2885

(4268621) Lupus anticoagulant assay

228

1787

1.27

3.17

2.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.78

3.16

2.5

1.5

2.07

1.88

mmol/24h

0.21

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

102

707

1.44

3.15

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

455

3835

1.19

3.15

1.6

1.3

45.52

51.69

u/ml

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

647

5611

1.15

3.14

1.6

1.7

9.79

13.34

u/ml

1.61

169

1487

(3051387) C reactive protein [Mass/volume] in Capillary blood

303

2458

1.23

3.12

3.8

3.2

25.71

25.80

mg/l

0.02

211

1665

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

732

6407

1.14

3.11

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

345

2839

1.22

3.10

2.2

0.00

g/l

-0.00

320

2677

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.42

3.08

1.3

1.4

6.92

3.24

mg/l

—

(3010503) CD19 cells [#/volume] in Blood

110

777

1.41

3.08

3.0

2.8

158.17

235.99

e6/l

0.68

110

753

(3002481) Calcium/Creatinine [Mass Ratio] in Urine

7.47

3.04

4.3

8.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

173

1.90

3.04

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

115

821

1.40

3.03

1.5

5.16

5.88

u/l

0.96

724

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.67

3.02

1.7

2.1

294.60

248.02

ug/l

0.36

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

383

1.59

3.01

2.6

2.0

1.90

1.70

ratio

0.55

369

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

291

1.68

3.01

1.5

1.2

11.66

11.75

pmol/l

0.01

111

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

588

5082

1.16

3.00

8.4

4.9

24.41

24.55

mmol/l

0.68

558

4798

(40761539) Cells [Type] in Urine sediment by Light microscopy

269

1.71

2.99

1.3

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

487

1.52

2.98

1.6

1.5

14.11

14.55

pmol/l

0.30

407

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

166

1260

1.32

2.96

1.1

1.3

—

23.96

u/ml

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

930

8297

1.12

2.95

2.1

2.3

7.75

7.61

ug/l

0.06

818

7332

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

347

1.61

2.93

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

172

1317

1.30

2.89

1.1

1.2

3.36

7.91

u/ml

0.61

426

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

177

1364

1.30

2.85

1.6

1.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

663

5804

1.14

2.85

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

682

1.42

2.82

1.2

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

682

1.42

2.82

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

649

1.43

2.81

1.6

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

171

1.87

2.81

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

305

1.63

2.80

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.18

2.79

1.1

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

762

6742

1.13

2.79

1.6

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

331

2745

1.21

2.79

1.1

0.40

0.39

u/ml

0.01

115

901

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

124

911

1.36

2.78

1.1

1528.02

1498.81

miu/ml

0.11

124

911

(3002523) Influenza virus A Ag [Presence] in Specimen

411

3477

1.18

2.77

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

275

2242

1.23

2.75

1.6

1.5

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

194

1.80

2.75

1.7

—

(3013637) Mi-2 Ab [Presence] in Serum

338

1.59

2.73

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

338

1.59

2.73

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

338

1.59

2.73

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

338

1.59

2.73

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

224

1.74

2.72

1.1

1.2

0.50

110.99

mg/l

1.90

164

(3050794) Legionella sp Ab [Presence] in Serum

104

2.11

2.71

1.3

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

355

2975

1.19

2.68

1.1

19.20

14.63

au/ml

0.41

757

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

366

3077

1.19

2.67

1.4

—

(3003740) Influenza virus B Ag [Presence] in Specimen

409

3473

1.18

2.66

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

667

1.41

2.62

1.3

151.10

161.35

mmol/24h

0.63

667

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

250

2030

1.23

2.62

1.3

1.2

11.53

16.71

u/ml

0.40

101

(3015076) Soybean IgE Ab [Units/volume] in Serum

157

1206

1.30

2.62

1.1

0.27

1.39

u/ml

1.79

374

(44813793) Dust mix specific IgE antibody measurement

156

1203

1.29

2.54

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

353

1.55

2.53

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1061

11586

0.91

2.53

1.5

1.6

1032.07

1003.59

mu/l

0.36

916

9997

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

185

1.78

2.52

1.8

1.6

20.00

16.04

nmol/l

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

389

3307

1.18

2.51

5.5

4.3

0.34

iu/ml

0.06

207

1794

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

370

1.54

2.50

1.2

97.50

83.12

0.68

(3024666) Lithium [Moles/volume] in Serum or Plasma

134

1015

1.32

2.49

14.4

13.5

0.65

0.60

mmol/l

1.14

124

942

(3034770) Mitochondria Ab [Titer] in Serum

477

4124

1.16

2.49

1.2

1.3

1076.67

982.75

titre

0.08

120

(3007566) Smooth muscle Ab [Titer] in Serum

487

4218

1.15

2.48

1.2

1.3

83.00

127.43

titre

1.77

432

(3023183) Ammonium ion [Moles/volume] in Plasma

321

2689

1.19

2.47

3.4

3.0

33.68

34.40

umol/l

0.23

299

2474

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

100

726

1.37

2.46

1.8

1.5

—

(3011648) Oxygen content in Venous blood

182

1438

1.26

2.46

8.9

4.8

11.20

11.09

0.15

182

1432

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

247

1.65

2.45

2.5

2.7

6.27

151.22

ug/l

0.68

247

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

199

1592

1.25

2.42

7.2

6.8

11.11

11.28

mg/l

0.22

184

1496

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

140

1074

1.30

2.39

1.4

11.49

11.63

umol/l

0.09

132

1020

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

213

1721

1.24

2.38

1.1

98.54

96.30

0.59

194

1630

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

605

5338

1.13

2.36

6.1

4.0

48.82

48.84

0.01

591

5256

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

775

1.35

2.35

1.2

1.1

—

(3018291) Platelet Ab [Presence] in Serum

4.10

2.35

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

457

1.46

2.34

3.4

2.7

161.20

115.75

ng/l

0.43

304

(3014133) Dog dander IgE Ab [Units/volume] in Serum

381

3255

1.17

2.34

1.1

6.40

4.61

u/ml

0.42

197

1720

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.02

2.34

1.1

1.0

—

(3017704) Immunofixation for Urine

475

1.45

2.31

1.3

1.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

374

3195

1.17

2.31

1.5

1.4

4.03

3.83

ug/l

0.19

342

2918

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

126

1.90

2.27

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

441

3822

1.15

2.26

1.1

2.07

2.25

u/ml

0.15

232

2093

(3004716) Salmonella sp identified in Stool by Organism specific culture

913

8272

1.11

2.26

1.4

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.87

2.24

1.0

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

663

1.37

2.23

1.0

96.27

94.48

0.23

543

(3024891) Influenza virus A+B Ag [Presence] in Specimen

489

4276

1.14

2.21

1.2

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.09

2.21

1.2

1.5

3.11

2.58

mu/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

566

6345

0.88

2.21

1.5

65.07

61.73

ug/l

0.54

476

5380

(3027874) Urate [Moles/volume] in Urine

2.67

2.19

1.2

1.1

1.83

2.05

mmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

399

1.47

2.18

1.6

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

465

4062

1.14

2.15

2.1

1.9

3.30

2.02

ug/l

0.85

410

3639

(3034860) Kappa light chains.free [Mass/volume] in Serum

379

3263

1.16

2.14

3.2

3.3

47.47

65.95

mg/l

0.54

288

2787

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

257

1.59

2.13

2.5

2.8

44.95

29.92

mg/l

0.46

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

387

3341

1.16

2.11

1.4

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

181

1.71

2.11

1.8

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

553

1.39

2.08

1.1

67.95

323.60

ng/l

0.97

137

(3037756) Immunofixation for Serum or Plasma

237

1967

1.20

2.08

1.5

1.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

340

2912

1.17

2.07

2.9

3.1

3.13

2.81

ratio

0.10

179

1638

(43055514) Macroprolactin [Presence] in Serum or Plasma

521

1.40

2.05

1.3

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

154

1224

1.26

2.04

1.7

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

183

1.69

2.04

1.7

1.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

377

3260

1.16

2.03

3.2

3.3

40.52

44.39

mg/l

0.15

287

2786

(3008536) Aspergillus sp Ab [Presence] in Serum

253

1.58

2.02

1.8

2.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

288

2440

1.18

2.01

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

307

2615

1.17

2.01

2.3

0.91

0.84

nmol/l

0.79

264

2244

(3038071) Oxygen [Partial pressure] in Mixed venous blood

301

1.52

2.01

4.5

6.9

5.17

5.51

kpa

0.94

301

(3020911) Cortisol [Moles/time] in 24 hour Urine

574

1.37

2.00

1.5

1.4

70.30

150.88

nmol/24h

1.79

574

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

600

1.36

1.99

2.1

2.0

153.55

154.59

0.03

569

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

114

876

1.30

1.99

1.8

1.6

—

(3036180) Methadone [Presence] in Urine

2.80

1.98

5.2

2.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

231

1924

1.20

1.97

3.8

3.5

1.15

1.48

1.09

206

1749

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

109

834

1.30

1.96

1.6

2689484.33

1729015.27

iu/ml

—

(3046861) Legionella sp Ag [Presence] in Urine

2.27

1.95

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

344

1.48

1.94

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

369

1.46

1.93

1.2

81.18

73.37

0.25

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

166

1341

1.24

1.92

1.1

8.67

7.25

iu/ml

0.29

345

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

194

1.64

1.92

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

187

1532

1.22

1.90

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

539

5994

0.89

1.88

1.5

0.94

ratio

0.01

308

3603

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

539

5994

0.89

1.88

1.5

1.23

1.19

ratio

0.40

310

3632

(3051101) Glucose [Moles/volume] in Cord blood

155

0.39

1.88

2.8

5.9

7.33

8.26

mmol/l

—

155

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

315

1.49

1.86

1.1

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.15

1.86

1.4

2.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

278

2369

1.17

1.84

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

415

1.42

1.83

1.1

39.99

30.37

iu/ml

0.50

415

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

187

1540

1.21

1.82

1.4

1.5

—

(3028433) Virus identified in Specimen by Culture

424

1.41

1.81

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

706

1.31

1.80

1.8

1.13

1.29

nmol/l

0.80

528

(3005988) Vibrio sp identified in Specimen by Organism specific culture

187

1542

1.21

1.80

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

539

5972

0.90

1.78

1.5

1.20

1.15

ratio

0.66

308

3580

(3006442) Creatine [Moles/volume] in Serum or Plasma

111

865

1.28

1.77

1.4

91.72

79.52

umol/l

0.40

111

865

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

111

867

1.28

1.75

1.4

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

959

0.75

1.72

1.0

1.1

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

281

1.49

1.70

1.3

48.74

40.70

0.79

194

(3004446) Plasmodium sp identified in Blood by Light microscopy

155

1.67

1.69

2.6

2.5

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.90

1.67

2.0

1.5

376.00

303.79

umol/24h

0.42

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

465

1.37

1.67

4.4

3.9

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

171

1.63

1.67

4.0

3.6

8.66

5.49

0.41

(37208534) Antinuclear antibody arbitrary concentration in serum

542

1.34

1.67

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

689

1.30

1.67

1.3

1.2

75.59

80.01

u/l

0.24

618

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

604

1.32

1.64

1.2

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

613

1.32

1.63

2.0

2.4

9.73

9.23

mg/l

0.42

512

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

241

2055

1.17

1.63

1.3

—

16.00

—

(3017509) Phencyclidine [Presence] in Urine

220

1.54

1.61

2.4

1.7

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

129

1582

0.81

1.61

1.6

1.5

—

(3018405) Lactate [Moles/volume] in Arterial blood

385

3398

1.13

1.61

3.9

1.34

1.39

mmol/l

0.43

378

3327

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

332

2902

1.14

1.61

1.4

24.60

25.35

u/l

0.14

268

2384

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1307

13853

0.93

1.60

4.6

4.4

31.92

32.16

0.34

924

9833

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

196

1645

1.19

1.60

1.4

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

628

5698

1.10

1.60

1.4

—

(4035726) Immunohistochemistry procedure

1113

10354

1.08

1.58

1.5

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

113

1.76

1.58

1.6

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

533

5862

0.90

1.57

1.5

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

262

1.48

1.57

1.1

1.0

0.03

1.11

u/ml

1.52

123

(3016031) Almond IgE Ab [Units/volume] in Serum

198

1.56

1.1

0.46

1.28

u/ml

1.17

125

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

312

1.44

1.55

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

113

903

1.25

1.51

1.8

2.19

3.01

u/ml

0.49

268

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1505

14172

1.06

1.51

1.7

1.6

3.43

3.46

mmol/l

0.52

979

9459

(3022493) Free Hemoglobin [Mass/volume] in Plasma

604

1.30

1.51

5.3

4.9

72.46

1635.13

mg/l

1.57

450

(3024522) Salmonella sp identified in Specimen by Organism specific culture

191

1610

1.18

1.50

1.4

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

130

1.69

1.50

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

683

1.28

1.50

1.3

1.2

18.22

20.79

u/l

0.25

614

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

265

1.47

1.50

1.1

0.15

2.52

u/ml

0.85

123

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

161

1.61

1.49

1.0

0.40

1.46

u/ml

0.70

132

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.15

1.49

3.3

6.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

937

8689

1.08

1.47

1.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2500

23896

1.05

1.47

2.4

2.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.99

1.47

1.5

1.6

—

(21494434) Karyotype in Bone marrow

119

961

1.24

1.46

1.1

1.2

—

(3032641) Amino acids panel - Urine

2.21

1.45

1.1

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

462

1.34

1.43

1.7

1.9

239.96

124.59

au/ml

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.87

1.42

1.1

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

236

1.48

1.41

1.0

1.1

1.01

0.33

u/ml

0.35

108

(3010370) Gastrin [Moles/volume] in Serum or Plasma

228

1.49

1.40

1.5

2.1

154.02

45.84

pmol/l

0.40

199

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

180

1.55

1.40

2.0

1.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

603

1.29

1.39

1.1

—

0.75

—

(3034426) Prothrombin time (PT)

490

1.32

1.39

1.1

1.2

28.54

28.13

0.23

490

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

149

1242

1.20

1.36

1.2

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

2.19

1.36

1.0

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

623

1.28

1.36

1.3

11.83

13.23

u/l

0.38

581

(3034274) Bile acid [Moles/volume] in Serum --fasting

339

3007

1.13

1.35

2.7

2.5

7.58

6.86

umol/l

0.30

259

2232

(3043238) Trisomy 21 risk [Likelihood] in Fetus

452

4966

0.90

1.35

1.6

—

(3026470) Cobalt [Mass/volume] in Blood

510

1.31

1.35

2.4

2.3

2.96

3.67

ug/l

0.54

476

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

158

1326

1.19

1.34

2.4

2.0

16.78

25.49

mg/l

2.08

500

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

347

3085

1.12

1.34

1.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

239

1.46

1.34

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.13

1.33

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

298

1.40

1.32

1.3

1.7

28.68

31.83

u/l

0.09

275

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

118

966

1.22

1.31

1.1

1.2

1.06

ratio

0.13

814

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

189

1615

1.17

1.30

1.4

1.5

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.49

1.29

1.2

1.17

1.66

mg/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.80

1.29

1.2

1.7

41.00

46.46

umol/l

0.23

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

307

3433

0.89

1.28

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

328

2916

1.12

1.28

1.7

1.6

8197.75

12703.89

e6/l

1.76

229

2054

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.84

1.28

1.8

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

638

1.27

1.8

1.7

3745.45

2825.26

titre

0.35

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

719

1.25

1.26

1.3

1.5

24.00

21.32

u/ml

0.33

130

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

830

7718

1.08

1.25

2.9

3.2

70.99

47.73

u/ml

0.28

805

7471

(3004775) Volume in Urine collected for unspecified duration

729

1.24

1.25

2.4

706.57

647.77

0.60

532

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

158

1337

1.18

1.24

1.2

1.1

18.86

17.58

u/ml

0.16

536

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

130

1.61

1.24

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

1.59

1.24

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

641

1.26

1.23

1.1

29.86

23.40

u/ml

0.07

418

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2695

25916

1.04

1.23

2.5

2.3

—

(3003129) Base excess in Capillary blood by calculation

156

1320

1.18

1.23

2.7

2.2

0.18

0.61

mmol/l

0.75

146

1256

(3041354) Potassium [Moles/volume] in Venous blood

123

1019

1.20

1.23

2.8

2.1

4.08

4.03

mmol/l

0.74

123

1008

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

294

1.39

1.23

1.1

1.2

7.33

3.67

u/ml

0.50

245

(40763791) Oxygen content in Venous blood by calculation

2.15

1.21

5.4

8.2

12.39

12.54

ml/dl

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

447

4879

0.91

1.20

1.5

—

(3000330) Specific gravity of Urine by Test strip

538

5819

0.92

1.19

3.6

3.0

1.02

ratio

0.37

472

5186

(3019832) Treponema pallidum Ab [Presence] in Serum

2334

22397

1.04

1.18

1.8

1.9

—

(3052592) Norovirus Ag [Presence] in Stool

180

1.49

1.18

1.2

1.3

—

(3025577) Chromium [Mass/volume] in Blood

495

1.29

1.18

2.3

1.80

2.51

ug/l

1.57

421

(3033942) Copper [Moles/time] in 24 hour Urine

1.82

1.17

1.0

1.5

0.24

0.88

umol/24h

—

(44806071) Cardiolipin IgM antibody measurement

235

0.59

1.15

1.1

—

(3035285) Chloride [Moles/volume] in Venous blood

122

1018

1.20

1.15

2.8

2.1

105.98

105.50

mmol/l

0.56

122

1007

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

367

1.33

1.14

1.6

9.44

8.92

ug/l

0.41

367

(3020650) Glucose [Presence] in Urine

528

0.73

1.13

2.0

1.5

0.08

0.03

estimate

0.27

528

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.72

1.13

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

182

1.48

1.13

1.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

552

1.26

1.12

2.1

7.92

7.94

mmol/l

0.01

552

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.32

1.12

1.0

1.4

1.58

2.10

g/l

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

216

1.43

1.11

1.5

1.3

312.00

53.77

titre

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

183

1.47

1.11

1.3

1.2

1.81

1.71

mmol/l

0.18

118

(3048929) Epstein Barr virus Ab [Presence] in Serum

711

6611

1.07

1.10

1.5

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

119

995

1.19

1.10

2.8

2.2

1.20

mmol/l

0.46

119

984

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

111

1.62

1.10

1.1

1.0

—

(3008037) Lactate [Moles/volume] in Venous blood

274

2438

1.12

1.10

4.0

2.9

1.40

1.52

mmol/l

1.41

258

2370

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

219

0.59

1.10

1.0

1.1

1.00

1.18

mom

0.71

219

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1058

0.82

1.09

2.1

1.8

115.85

941.13

pmol/l

0.80

148

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

751

1.22

1.09

1.6

1.5

7.84

6.17

u/l

0.62

604

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

200

1.44

1.09

1.4

1.6

97.55

58.55

ng/l

0.41

122

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

143

1.53

1.09

1.2

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

143

1.53

1.09

1.1

1.0

6.72

20.11

u/ml

2.14

116

(3022621) pH of Urine by Test strip

1132

10694

1.06

1.08

2.5

2.4

6.19

6.12

1.68

713

6843

(3036782) Glucose [Moles/volume] in Pleural fluid

113

943

1.19

1.08

1.3

6.16

6.18

mmol/l

0.03

104

880

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

266

2367

1.12

1.07

1.1

2.02

2.63

0.57

424

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

729

6798

1.07

1.06

1.3

241.60

226.27

miu/ml

0.53

331

3317

(3005033) Fetal Nuchal fold Thickness US

439

4758

0.92

1.05

1.5

1.25

1.26

0.16

325

3531

(3029396) Erythrocyte agglutination [Presence] in Blood

644

0.77

1.04

2.8

3.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

124

0.48

1.04

1.0

1.3

—

(4146454) Self-monitoring of blood glucose

1062

0.82

1.04

3.2

2.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

105

1.61

1.04

1.1

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

118

993

1.18

1.04

2.4

2.7

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

721

6727

1.07

1.03

1.7

1.8

0.27

0.30

mg/l

0.60

285

3131

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

346

0.69

1.03

3.1

1.9

60266.08

15193.82

e6/l

0.56

162

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.26

1.03

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

445

1.28

1.01

3.1

2.7

0.61

mmol/l

0.06

445

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

106

1.60

1.01

1.2

0.60

0.52

u/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

196

1720

1.14

1.00

1.8

—

(3041672) Baker's yeast Ab [Presence] in Serum

130

1.53

1.00

1.1

—

(3016879) Cocaine [Presence] in Urine

940

8859

1.06

1.00

2.3

2.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

144

1238

1.16

0.99

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

277

2485

1.11

0.99

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.64

0.99

1.1

1.0

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

110

926

1.18

0.98

2.0

1.8

4.32

3.52

mg/l

0.75

105

888

(4211845) Urine protein measurement

637

0.78

0.98

3.3

2.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

491

0.75

0.97

1.1

1.3

76.92

68.10

ug/l

0.49

491

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

155

1342

1.15

0.97

1.2

85.88

63.53

u/l

0.43

132

1177

(4281824) Cell count and differential, peritoneal fluid

120

1398

0.85

0.97

1.2

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

271

0.66

0.97

1.8

1.9

1.78

3.24

ug/l

—

167

(3036048) Francisella tularensis Ab [Titer] in Serum

343

1.31

0.96

1.1

240.00

364.21

titre

—

(3016750) Collection duration of Urine

556

1.24

0.96

2.4

2.3

505.77

499.78

min

0.17

443

(3008116) Ketones [Moles/volume] in Urine by Test strip

292

1.33

0.95

2.1

1.4

0.30

0.44

mmol/l

—

(3000093) Morphology [Interpretation] in Blood Narrative

134

1152

1.16

0.93

1.3

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

380

1.29

0.93

1.5

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

199

1.40

0.93

5.5

5.4

49.35

40.43

ug/min

0.33

137

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.64

0.92

1.9

1.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

505

1.24

0.92

1.2

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

148

1284

1.15

0.92

1.8

1.5

1.28

promille

0.01

125

987

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.71

0.91

4.5

5.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

578

1.22

0.91

1.6

2.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

578

1.22

0.91

1.6

2.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

678

1.21

0.90

1.0

760.57

751.95

ng/l

0.06

488

(3004616) Nuclear Ab [Presence] in Serum

196

1737

1.13

0.89

1.4

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

159

1.44

0.89

1.2

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3314

32199

1.03

0.89

2.5

2.3

—

(4038314) Semen analysis, post vasectomy

118

1.52

0.89

1.1

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

176

1.42

0.88

1.4

1.8

12.54

9.00

u/ml

0.11

152

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

151

1.45

0.88

1.4

69.67

57.84

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

680

1.20

0.88

1.0

42.28

39.99

ng/l

0.22

499

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.85

0.87

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

476

4412

1.08

0.86

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

147

1283

1.14

0.85

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

774

1.18

0.85

1.6

1.7

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

246

1.34

0.85

1.4

3.88

2.81

0.25

212

(3002621) Streptococcal DNAse B [Units/volume] in Serum

195

1.38

0.84

1.0

1.1

227.67

309.76

u/ml

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

530

1.22

0.84

1.1

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

1.75

0.82

1.3

1.4

6.00

0.50

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

162

1.41

0.82

1.1

11.46

38.44

u/ml

—

(3032057) Clostridioides difficile [Presence] in Stool

196

1.37

0.82

1.9

2.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

696

1.19

0.81

6.0

6.6

40.27

5811.43

u/ml

0.59

125

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.87

0.81

1.0

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

724

1.18

0.81

1.2

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

212

0.66

0.80

1.3

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

286

2605

1.10

0.80

1.1

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

1001

9524

1.05

0.79

2.3

2.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

155

1.41

0.79

1.1

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.79

0.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

589

6227

0.94

0.79

1.1

0.64

0.62

ratio

0.21

667

(3006270) Folate [Moles/volume] in Blood

104

892

1.16

0.79

1.1

380.49

390.83

nmol/l

0.21

795

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.81

0.78

1.0

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1941

18735

1.04

0.78

2.0

1.9

3.38

3.45

ratio

2.00

1430

13968

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

139

1218

1.14

0.78

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

828

1.17

0.78

5.6

7.2

6.11

74.22

ug/l

1.77

565

(3038515) Glucose [Moles/volume] in Venous blood

220

1982

1.11

0.78

4.3

3.0

7.43

7.36

mmol/l

0.10

209

1928

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

181

1.38

0.78

10.8

14.3

0.47

0.38

umol/l

0.35

170

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

114

1.49

0.78

1.6

1.4

1.62

1.41

ml/s/173m2

—

(3014271) Vancomycin [Susceptibility]

365

1.26

0.77

2.7

2.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

410

4383

0.93

0.77

1.5

58.46

60.04

ug/l

0.34

410

4383

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.58

0.76

1.1

1.0

11.60

15.39

iu/ml

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

131

1.45

0.76

1.4

1.3

156.31

300.73

u/l

0.27

101

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

225

1.33

0.76

1.0

82.89

74.46

ug/l

0.59

188

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

393

1.24

0.75

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.69

0.75

1.0

1.4

—

(4015189) Microbial culture of sputum

231

0.69

0.74

1.4

2.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

235

1.31

0.73

1.1

1.80

1.76

u/ml

0.01

169

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

589

0.81

0.73

1.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

157

1394

1.12

0.73

1.3

1.2

53.17

42.75

u/ml

0.20

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

677

1.18

0.73

1.0

333.13

310.19

ng/l

0.29

505

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

114

992

1.15

0.73

1.5

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

114

992

1.15

0.73

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

114

992

1.15

0.73

1.5

1.7

—

(3019225) pH of Specimen

1100

10519

1.04

0.72

4.2

4.0

7.36

0.71

772

7586

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

1.99

0.72

1.0

1.4

118.20

75.00

e6/l

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

258

2355

1.09

0.72

2.0

2.4

13.12

0.05

253

2330

(3027231) Wheat IgE Ab [Units/volume] in Serum

468

1.21

0.72

1.1

1.2

0.44

5.55

u/ml

1.63

420

(3011841) English Walnut IgE Ab [Units/volume] in Serum

289

1.28

0.71

1.1

1.2

1.08

6.53

u/ml

2.96

242

(3028300) Cannabinoids [Presence] in Urine

1005

9597

1.05

0.71

2.3

2.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

716

1.17

0.71

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

140

1241

1.12

0.69

4.0

3.7

—

(3000034) Microalbumin [Mass/volume] in Urine

981

0.86

0.68

3.2

2.9

23.98

58.20

mg/l

1.87

722

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

405

0.79

0.66

1.8

1.9

40.89

40.45

g/l

0.18

405

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

667

0.84

0.66

2.0

1.9

—

(3027008) Opiates [Presence] in Urine

1000

9569

1.04

0.66

2.3

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

101

1147

0.88

0.65

1.3

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

242

2620

0.92

0.65

1.2

1.3

—

(3033099) Centromere Ab [Titer] in Serum

356

1.23

0.65

1.2

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

704

1.16

0.65

1.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.51

0.65

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

143

1276

1.12

0.64

1.4

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

223

1.30

0.64

1.2

1.4

—

(3006462) Nitrate [Presence] in Urine

578

0.83

0.64

3.3

2.8

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.72

0.63

1.6

1.5

305.80

434.17

mg/24h

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

121

1071

1.13

0.63

1.5

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.63

0.61

1.0

6.70

4.23

u/ml

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

287

1.25

0.61

1.6

0.52

0.40

ug/l

0.54

219

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

225

1.28

0.61

1.4

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

396

1.21

0.60

3.4

2.08

1.92

ratio

0.34

358

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

138

0.65

0.60

1.1

0.05

0.06

u/ml

—

138

(3001556) Androgen free Index in Serum or Plasma

208

1.29

0.60

1.1

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

205

2224

0.92

0.60

3.1

3.8

238.52

542.34

u/ml

1.05

186

2026

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

497

1.18

0.60

1.1

1.2

29.93

8.19

u/ml

0.59

346

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

139

1535

0.90

0.59

1.4

—

titre

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

200

1.30

0.59

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

164

1485

1.10

0.58

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

255

2355

1.08

0.58

2.7

2.4

105.68

107.59

ug/min

0.03

143

1471

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

207

0.72

0.57

1.1

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.56

0.57

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

114

1.40

0.57

1.1

1.0

0.15

0.29

u/ml

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

816

1.14

0.57

1.5

1.3

574.28

388.22

u/l

0.42

778

(3032352) Blasts [#/volume] in Cerebral spinal fluid

175

1.31

0.56

3.7

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

149

1.34

0.56

1.2

1.3

2.97

1.91

mmol/l

0.24

106

(40768793) Breast Pathology biopsy report

349

3267

1.07

0.55

1.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.45

0.55

1.1

1.0

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

211

1.27

0.55

1.1

0.06

0.62

u/ml

0.82

211

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

129

1158

1.11

0.55

1.4

1.2

95.00

68.57

u/ml

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.55

1.2

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

716

1.14

0.55

3.9

4.1

9.43

8.70

mg/l

0.49

585

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

502

0.83

0.54

1.9

2.0

16.42

126.36

ug/min

1.37

111

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.57

0.54

2.0

4.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

203

1.28

0.54

1.2

1.1

—

(3042517) Benzodiazepines panel - Urine

257

1.24

0.53

3.2

2.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

192

2073

0.92

0.53

4.1

3.9

18.73

28.68

u/ml

4.48

187

2000

(3044007) Cell count panel - Peritoneal fluid

348

0.80

0.53

2.1

2.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1071

11019

0.97

0.52

3.9

4.4

19.47

24.66

ug/l

0.21

795

8692

(3028717) Thiamine [Mass/volume] in Blood

204

1.27

0.52

1.1

1.2

60.69

64.04

ug/l

0.42

204

(3044927) Protein electrophoresis panel - Urine

880

1.12

0.51

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.40

0.51

1.2

1.0

—

(3011436) Histone Ab [Units/volume] in Serum

259

1.23

0.50

1.1

—

8.00

u/ml

—

(3038026) Centromere Ab [Units/volume] in Serum

111

995

1.11

0.50

1.4

1.2

34.28

43.61

u/ml

—

(3025130) Human papilloma virus identified in Specimen

302

2828

1.06

0.50

1.8

1.9

—

(40758292) HTLV I+II Ab panel - Serum

305

1.21

0.50

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

410

0.83

0.49

3.2

44.47

0.00

410

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

480

1.16

0.49

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

639

1.14

0.49

3.0

3.1

143.64

126.26

au/ml

0.10

105

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

409

0.83

0.48

6.4

6.3

8.24

8.79

0.24

409

(3010144) Erythrocytes [#/volume] in Synovial fluid

118

1064

1.11

0.48

1.4

67587.16

98904.93

e6/l

0.46

712

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

154

1407

1.09

0.48

4.3

5.0

131.87

91.27

u/ml

0.45

481

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

677

1.13

0.48

1.0

10.26

11.90

u/ml

0.26

452

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.42

0.48

1.7

1.3

1.91

1.73

mg/l

0.22

(40765089) Chromosome analysis panel - Blood by G-banded

707

1.13

0.47

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.45

0.46

1.0

1.1

305.86

365.07

nmol/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

317

1.19

0.46

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.42

0.45

1.3

1.0

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

441

4190

1.05

0.45

1.9

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

405

0.84

0.45

3.0

2.2

12876.04

2741.32

e6/l

0.37

265

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

221

2058

1.07

0.45

1.1

1.45

1.48

g/l

0.60

203

1897

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

1.42

0.44

1.4

2.40

32.78

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

129

1.31

0.44

1.2

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

147

1348

1.09

0.44

1.7

2.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

139

1503

0.92

0.43

1.2

—

(4024509) Urine culture

555

5751

0.96

0.43

1.8

—

(3022670) pH of Venous cord blood

1.36

0.42

1.1

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

713

1.12

0.42

1.1

218.01

180.64

iu/ml

0.36

708

(3007463) Buprenorphine [Presence] in Urine

0.64

0.42

7.0

5.3

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

527

5463

0.96

0.42

1.6

—

(3024932) HLA-DR beta [Type]

479

1.14

0.41

1.1

—

(3045414) Leukocytes [Presence] in Urine

1217

12431

0.97

0.41

2.1

2.0

0.04

0.02

estimate

0.38

253

2767

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

461

1.15

0.41

4.3

3.4

0.94

1.21

0.65

461

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

603

1.12

0.40

2.5

2.6

158.09

150.66

nmol/l

0.23

541

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

123

1.30

0.39

1.2

1.1

—

(3014891) Appearance of Pleural fluid

103

0.68

0.39

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

315

1.17

0.38

1.1

1.3

37.99

39.53

g/l

0.18

163

(40768795) Lymph node Pathology biopsy report

135

1246

1.08

0.37

1.3

1.2

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

151

1.25

0.37

1.5

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

1.38

0.36

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

246

2322

1.06

0.36

4.6

3.7

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

732

1.10

0.36

1.1

1.2

2.00

11.80

u/ml

—

(3024471) HLA-A [Type]

487

1.13

0.35

1.0

—

(3027944) Amphetamines [Presence] in Urine

975

9476

1.03

0.33

2.3

1.9

—

(44806420) Estimation of glomerular filtration rate

180

1688

1.06

0.33

2.6

2.3

—

(3035880) pH of Pleural fluid

470

1.12

0.33

1.3

7.41

7.40

0.09

313

(3050129) First trimester maternal screen panel - Serum or Plasma

742

7597

0.97

0.33

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

133

1236

1.07

0.32

1.6

1.4

33.57

35.79

nmol/l

0.32

114

1138

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

202

2125

0.95

0.32

1.3

1.4

6.71

6.96

mmol/l

0.78

178

1911

(3017354) Segmented neutrophils/Leukocytes in Blood

133

1237

1.07

0.32

3.5

55.31

55.89

0.12

115

1077

(3023436) Glucagon [Mass/volume] in Serum or Plasma

1.35

0.31

2.0

2.1

171.60

193.21

ng/l

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

294

1.15

0.31

1.4

65.66

62.95

0.21

247

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.27

0.29

1.3

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.33

0.29

1.9

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.33

0.29

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

184

0.81

0.29

2.3

4.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

277

1.15

0.29

1.3

1.4

1.19

1.18

mmol/l

0.49

277

(40757373) Influenza virus identified in Isolate

212

1.17

0.29

2.1

1.5

—

(3002619) Bacteria identified in Specimen by Culture

362

1.13

0.29

1.3

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

258

0.85

0.28

1.4

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

783

1.08

0.27

1.2

9.18

9.82

mm/h

0.33

783

(40757494) Bilirubin.total [Moles/volume] in Blood

582

1.10

0.27

3.3

2.6

65.50

65.36

umol/l

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

139

1468

0.94

0.27

3.3

3.2

0.81

nmol/l

0.06

1163

(4133840) Spirometry

384

0.88

0.27

1.1

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

430

1.11

0.27

1.7

2.3

—

(3012441) Differential panel - Pleural fluid

101

938

1.07

0.27

1.4

1.5

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.68

0.26

1.2

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

114

1066

1.07

0.26

3.4

2.6

28.19

26.42

mg/l

0.19

748

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

196

1.17

0.26

6.5

7.4

11.28

10.64

0.45

196

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

318

1.13

0.26

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

423

1.11

0.25

1.7

2.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

423

1.11

0.25

1.7

2.3

—

(3012898) Urea [Moles/volume] in Urine

141

1.20

0.25

1.4

1.6

168.94

172.19

mmol/l

0.03

131

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

169

1.18

0.24

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.16

0.24

3.8

3.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.35

0.23

1.0

1.1

25.47

33.16

umol/24h

—

(40762814) Titanium [Mass/volume] in Blood

133

1.20

0.23

2.7

2.5

2.76

4.15

ug/l

—

(3013762) Body weight Measured

1.31

0.23

1.0

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

472

4578

1.03

0.23

2.0

—

(3019174) dRVVT (LA screen)

146

0.82

0.22

1.1

1.2

—

(3006598) pH of Arterial cord blood

312

1.12

0.22

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

312

1.12

0.22

1.0

-3.80

-1.98

mmol/l

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

312

1.12

0.22

1.0

7.24

7.28

kpa

0.04

266

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

115

1211

0.95

0.22

1.0

1.1

274.03

289.01

mg/l

1.33

102

1112

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

609

1.08

0.22

1.5

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

609

1.08

0.22

1.5

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

609

1.08

0.22

1.5

2.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.24

0.22

6.2

8.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.21

0.22

1.0

1.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

332

1.11

0.22

2.5

2.06

1.65

mmol/l

0.36

242

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

610

1.08

0.22

1.5

2.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

181

1.16

0.21

1.0

1.1

2.60

9.25

u/ml

3.36

105

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

4367

43199

1.01

0.21

1.6

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

951

0.94

0.20

1.6

1.5

0.49

0.52

e9/l

0.39

951

(3017569) Oxygen content in Arterial blood

535

1.08

0.20

2.4

2.3

16.64

16.16

0.53

535

(3005011) Chlamydia sp Ab [Titer] in Serum

239

1.13

0.20

1.7

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

1.20

0.19

7.0

7.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

826

0.94

0.19

1.3

1.4

5.49

5.50

mmol/l

0.01

785

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.17

0.19

1.0

1.1

257.67

344.85

pmol/l

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

231

1.12

0.18

1.3

1.2

9.53

310.94

ug/l

1.70

115

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

153

0.85

0.18

3.1

2.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

987

0.95

0.18

1.9

2.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

250

2418

1.03

0.17

1.1

94.02

4915.00

iu/ml

0.64

553

(40760409) HLA-A [Type] by High resolution

0.75

0.17

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.75

0.17

1.0

—

(40760410) HLA-B [Type] by High resolution

0.75

0.17

1.0

—

(3013862) HLA-DP [Type]

0.75

0.17

1.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

105

1095

0.95

0.16

1.4

3113.84

3359.42

e6/l

0.05

750

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

195

1.12

0.16

1.5

1.4

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.15

0.16

1.1

0.00

1.06

u/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

860

0.95

0.16

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.09

0.15

1.0

1.4

224.25

578.25

nmol/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.19

0.15

1.1

6.22

11.98

u/l

0.91

(3020876) Protein [Mass/time] in 24 hour Urine

129

1334

0.96

0.15

2.9

2.5

1.60

1.40

g/24h

0.27

780

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

159

1.13

0.14

10.3

10.6

6.90

5.57

mmol/l

0.42

159

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

457

0.94

0.13

2.9

2.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

909

1.04

0.12

1.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

782

1.04

0.12

1.3

1.2

29.72

20.83

u/l

0.34

655

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

137

0.87

0.12

1.2

1.1

101.33

92.26

titre

0.19

137

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.17

0.12

1.1

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

261

0.92

0.12

1.8

1.4

24.99

24.09

g/l

0.09

190

(40768806) Pleura Pathology biopsy report

942

0.96

0.12

1.5

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

219

0.91

0.11

2.5

2.8

1426.90

2137.71

u/l

0.25

196

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

804

1.04

0.11

1.3

1.2

109.78

86.25

u/l

0.45

692

(3003434) Protein [Mass/volume] in Pleural fluid

126

1219

1.03

0.10

1.5

1.4

33.49

34.17

g/l

0.27

113

1114

(3018001) Oat IgE Ab [Units/volume] in Serum

134

1.11

0.10

1.0

0.13

0.31

u/ml

—

(4198724) Urine methamphetamine measurement

968

0.97

0.10

2.6

2.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

149

1449

1.02

0.09

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.11

0.09

17.2

8.7

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.07

0.08

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

291

1.06

0.08

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.83

0.08

1.2

1.0

—

(40763590) HLA-DQ beta [Type]

0.77

0.08

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.07

0.08

1.3

2.0

0.81

0.66

umol/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.03

0.07

1.1

8.44

8.16

mmol/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.13

0.07

7.4

6.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.13

0.07

1.4

1.1

5.09

10.46

mg/l

—

(3009677) Dengue virus Ab [Presence] in Serum

1.06

0.07

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

371

1.05

0.07

1.6

1.8

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

205

1.07

0.07

2.0

2.3

7.01

7.59

mmol/l

0.53

114

(4212803) Bone marrow aspirate examination

1.03

0.07

1.2

1.1

—

(3026726) Creatinine [Moles/volume] in Specimen

0.87

0.06

1.9

2.5

139.25

425.06

umol/l

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

206

1.06

0.06

1.5

1.6

5.48

279076.08

nmol/l

1.44

172

(3010937) Rubella virus Ab [Presence] in Serum

128

1.09

0.06

1.2

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

127

1241

1.02

0.06

1.2

1.3

156.36

195.07

titre

0.28

213

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

696

0.97

0.06

1.1

4.94

11.81

u/ml

2.82

127

(3043410) Blood group antigens tested for on Red Blood Cells

313

0.95

0.06

2.4

1.7

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

195

1969

0.99

0.05

1.2

1.3

45.47

30.24

u/l

0.42

169

1724

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

256

1.05

0.05

1.2

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

124

1256

0.98

0.05

1.6

1.8

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

275

2711

1.01

0.05

1.7

1.5

—

(3022475) Manganese [Moles/volume] in Blood

1.11

0.05

1.4

1.3

0.17

0.16

umol/l

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

140

0.92

0.05

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

126

1236

1.02

0.04

1.5

1.4

1.52

1.49

nmol/l

0.10

113

1109

(3045424) Erythrocytes [Presence] in Urine

644

6381

1.01

0.04

2.2

2.1

1.26

0.02

estimate

0.49

200

2231

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

268

1.04

0.04

1.0

39.45

7.53

u/ml

0.57

268

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

209

1.05

0.03

1.0

1.1

0.23

0.62

u/ml

—

109

(3028308) Erythrocytes [#/volume] in Pleural fluid

961

0.98

0.03

1.4

35524.31

52242.42

e6/l

0.43

517

(3020356) Listeria sp identified in Specimen by Organism specific culture

128

0.93

0.03

1.2

1.1

—

(4034850) Laboratory test

375

3756

0.99

0.03

7.9

8.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

221

2184

1.01

0.03

1.2

0.67

1.08

1.11

101

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

626

1.02

0.03

1.3

50.00

56.04

titre

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

838

0.99

0.02

2.5

1.9

1.60

1.63

u/field

0.03

477

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

647

1.02

0.02

1.3

745.71

559.47

titre

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

340

3402

1.00

0.02

1.4

93.28

122.19

pmol/l

1.16

328

3313

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

132

1.06

0.02

1.5

1.4

4.86

11.28

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

787

0.99

0.02

1.2

—

(3024263) Appearance of Synovial fluid

588

1.02

0.02

2.1

1.7

—

(40765096) Chromosome analysis panel by Banding

340

1.03

0.02

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

142

1.05

0.02

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

142

1.05

0.02

1.1

1.3

—

(40768800) Prostate Pathology biopsy report

161

1613

0.99

0.01

1.3

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

106

0.94

0.01

1.1

—

(21494755) Public health laboratory ask at order entry panel

1657

16488

1.00

0.01

1.4

1.3

—

(40768441) Liver Pathology biopsy report

107

1059

1.01

0.00

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

155

0.96

0.00

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

168

1.01

0.00

1.6

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

187

1.01

0.00

2.4

1.9

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

188

1.01

0.00

1.4

1.3

5.97

5.71

mmol/l

0.71

188

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

604

1.01

0.00

1.5

1.6

1.37

2.77

u/field

1.83

435

(3020491) Glucose [Moles/volume] in Blood

955

1.00

0.00

2.0

1.8

6.86

6.27

mmol/l

1.01

719

(3045788) Cell count panel - Pleural fluid

907

1.00

0.00

1.4

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

295

1.01

0.00

1.5

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

106

1.03

0.00

1.4

1.3

—

485.13

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

409

4072

1.00

0.00

3.2

3.8

170.91

1839.31

u/ml

1.62

350

3515

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

120

1.00

0.00

1.1

—

(3003577) Lead [Moles/volume] in Blood

128

1.01

0.00

1.0

1.4

—

0.20

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

522

0.99

0.00

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

522

0.99

0.00

1.4

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

748

1.00

0.00

1.2

1.3

929.41

1014.49

titre

0.25

138

(3048879) Bone marrow aspiration report

253

0.98

0.00

2.6

2.2

—

2.00

—

(3047189) Immunofixation for 24 hour Urine

432

0.99

0.00

1.7

1.9

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

-0.00

0.0

1.0

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.3

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.97

-0.00

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

0.94

-0.00

1.0

0.01

0.05

u/ml

—

(3001729) Color of Synovial fluid

0.94

-0.00

1.6

1.5

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.8

—

15.00

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

2.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

32.09

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

207.44

—

Mortality – FinRegistry

↥

Association

Association between endpoint H7_REFRAACCOMMODIS and mortality.

Females

Parameter	HR [95% CI]	p-value
H7_REFRAACCOMMODIS	1.15 [1.03, 1.29]	0.016
Birth year	0.996 [0.99, 1.0]	0.323

During the follow-up period (1.1.1998 — 31.12.2019), 2935 out of 56112 females with H7_REFRAACCOMMODIS died.

Males

Parameter	HR [95% CI]	p-value
H7_REFRAACCOMMODIS	1.248 [1.09, 1.43]	0.001
Birth year	0.985 [0.98, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 2510 out of 44720 males with H7_REFRAACCOMMODIS died.

Mortality risk

Mortality risk for people of age

years, who have H7_REFRAACCOMMODIS.

N-year risk	Females	Males
1	0.114%	0.227%
5	0.712%	1.458%
10	1.848%	3.313%
15	3.315%	6.2%
20	5.755%	10.422%

Relationships between endpoints

↥

Index endpoint: H7_REFRAACCOMMODIS – Disorders of refraction and accommodation

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of refraction and accommodation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints